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Abstract
Many studies have suggested that oxidative stress plays an important role in the
pathophysiology of both multiple sclerosis (MS) and its animal model
experimental autoimmune encephalomyelitis (EAE). Yet, the mechanism by
which oxidative stress leads to tissue damage in these disorders is unclear.
Recent work from our laboratory has revealed that protein carbonylation, a major
oxidative modification caused by severe and/or chronic oxidative stress
conditions, is elevated in MS and EAE. Furthermore, protein carbonylation has
been shown to alter protein structure leading to misfolding/aggregation. These
findings prompted me to hypothesize that carbonylated proteins, formed as a
consequence of oxidative stress and/or decreased proteasomal activity,
promote protein aggregation to mediate neuronal apoptosis in vitro and in
EAE. To test this novel hypothesis, I first characterized protein carbonylation,
protein aggregation and apoptosis along the spinal cord during the course of
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myelin-oligodendrocyte glycoprotein (MOG)35-55 peptide-induced EAE in C57BL/6
mice [Chapter 2]. The results show that carbonylated proteins accumulate
throughout the course of the disease, albeit by different mechanisms: increased
oxidative stress in acute EAE and decreased proteasomal activity in chronic
EAE. I discovered not only that there is a temporal correlation between protein
carbonylation and apoptosis but also that carbonyl levels are significantly higher
in apoptotic cells. A high number of juxta-nuclear and cytoplasmic protein
aggregates containing the majority of the oxidized proteins are also present
during the course of EAE, which seems to be due to reduced autophagy.

In chapter 3, I show that when gluthathione levels are reduced to those in EAE
spinal cord, both neuron-like PC12 (nPC12) cells and primary neuronal cultures
accumulate carbonylated proteins and undergo cell death (both by necrosis and
apoptosis). Immunocytochemical and biochemical studies also revealed a
temporal/spatial relationship between carbonylation, protein aggregation and
cellular apoptosis. Furthermore, the effectiveness of the carbonyl scavenger
hydralazine, histidine hydrazide and methoxylamine at preventing cell death
identifies protein carbonyls as the toxic species. Experiments using wellcharacterized apoptosis inhibitors place protein carbonylation downstream of the
mitochondrial transition pore opening and upstream of caspase activation. These
in vitro studies demonstrate for the first time a causal relationship between
carbonylation, protein aggregation and apoptosis of neurons undergoing
oxidative damage.

This relationship was further strengthened with the
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experiments carried out in chapter 4, which show that inhibition of protein
aggregation with congo red (CR) or 2-hydroxypropyl β-cyclodextrin (HPCD)
significantly reduced neuronal cell death without affecting the levels of oxidized
proteins. Interestingly, large, juxta-nuclear aggregates are not formed upon GSH
depletion, suggesting that the small protein aggregates are the cytotoxic species.
Together, our data suggest that protein carbonylation causes protein aggregation
to mediate neuronal apoptosis in vitro and that a similar mechanism might be
contributing to neuronal/glial apoptosis in EAE. These studies provide the basis
for testing protein carbonylation scavengers and protein aggregation inhibitors for
the treatment of inflammatory demyelinating disorders.
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1. INTRODUCTION
1.1 Multiple sclerosis and experimental autoimmune encephalomyelitis
Multiple sclerosis (MS) is a highly heterogeneous, inflammatory disease of the
central nervous system (CNS) affecting 350,000 people in US and 2.5 million
worldwide (Fox, 2010). Although not firmly established, the occurrence of MS can
be traced back to medieval times; however, Dr. Jean-Martin Charcott made the
first official description of MS in 1868. The mean age for the onset of MS is 30
years, but can occur at any age. Women are twice as likely as men to be affected
by MS in life, and the peak age of onset is about five years earlier for women
than for men (Alonso and Hernan, 2008).
There are no symptoms exclusive to MS but many clinical features describe this
demyelinating disorder, such as fatigue, depression, cognitive dysfunction, body
aches, sleeping disorders, impairment of speech, vision and skeletal-muscle,
coordination, failure of several organs (bowel/bladder/sexual dysfunction) and
paralysis in severe episodes. There are several forms of MS based on the clinical
course. Relapsing-remitting MS is the most common form of the disease, where
patients experience a period of active symptoms (relapsing), after which the
symptoms resolve spontaneously (remitting). With the continuous tissue damage
that occurs over the years, patients develop the secondary progressive form of
MS, in which symptoms become chronic and gradually worsen with no distinct
remissions. In some patients MS symptoms become progressively worse from
the onset without any clinical relapse, which defines primary progressive MS.
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Progressive-relapsing MS is the least common type of MS, and refers to a steady
worsening of symptoms over time accompanied by progressive relapses
(McDonnel and Hawkins, 1996).

MS is considered as a T cell-dependent immune disorder associated with
inflammation and infiltration of T cells, B cells and macrophages into the CNS. T
cell-mediated macrophage and microglial activation, driven by myelin-specific
autoantigens (Witherick et al, 2011), leads to severe tissue injury and chronic
neurodegeneration. Often these inflammatory infiltrated cells form a localized
region around veins, which represent the highly heterogeneous MS-like lesions
or MS plaques. Many reports demonstrate massive oligodendrocyte death
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(Henderson, 2009) and neuronal destruction (Vercellino et al., 2009) caused by
inflammation and the ensuing oxidative stress (Keegan and Noseworthy, 2002).
Experimental autoimmune encephalomyelitis (EAE), also called experimental
allergic encephalomyelitis, is frequently used as an animal model of MS because
it closely shares both clinical and pathological features with the human disease.
The use of EAE animals helps to explore the mechanistic basis of the disease
and also to develop and test new therapeutic interventions for MS patients (Gold
et al., 2000; Constantinescu et al., 2011). EAE in rodents is an acute or chronicrelapsing, inflammatory and demyelinating autoimmune disease. EAE can be
induced by active immunization with myelin-specific antigens or by adoptive
transfer of T-cells from immunized animals into naive animals. The animals used
for this dissertation are female C57BL/6 mice in which EAE was induced by
active immunization of myelin oligodendrocyte glycoprotein (MOG) peptide 35-55
in complete Freund’s adjuvant (CFA). These animals were sacrificed at different
times during the disease course to represent the acute or chronic phases of MS
(Figure 1). Acute EAE was defined as having maximal neurological symptoms
without any improvement for at least three consecutive days. Chronic EAE was
defined arbitrarily as animals that remain in the stationary phase of the disease
for 30 days (60 DPI). I used spinal cord of these animals for investigating the
potential relationship between protein carbonylation and apoptosis because (1)
both oxidative stress and cell death has been previously documented in this
region (Smerjac and Bizzozero, 2008; Keegan and Noseworthy, 2002) and (2)
this area is normally affected in MS. It is noteworthy that while there is evidence
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validating cell death in EAE (Meyer et al., 2001; Das et al., 2008, Keegan and
Noseworthy, 2002), a detailed characterization of cell death in EAE spinal cord in
relation to specific biochemical and cellular alterations was lacking, which
prompted me to initiate these studies.
1.2 Oxidative stress and cell death in MS and EAE
Reactive oxygen species (ROS) are the end products of normal aerobic cellular
metabolism. Under normal conditions, these species are rapidly removed by the
cellular antioxidant system to prevent their excessive buildup (Uttara et al.,
2009). However, when cellular antioxidant defenses are insufficient to keep ROS
below a harmful threshold, oxidative stress (OS) develops (Schulz et al., 2000).
The outcomes of severe OS are molecular, cellular and tissue damage. Oxidative
modification of intracellular lipids, proteins and DNA lead to cellular apoptosis
and/or necrosis (Chandra, 2009). Apoptosis is characterized by cell shrinkage,
membrane blebbing, nuclear condensation and DNA fragmentation while
necrosis is differentiated by rapid cytoplasmic swelling, rupture of the plasma
membrane and organelle breakdown (Figure 2), (Majno and Jorris, 1995). The
extent and duration of the exposure to ROS determine the mechanism of cell
death. It is believed that necrotic cell death occurs under more severe forms of
OS than those necessary to elicit apoptotic cell death (Chandra, 2009).
Excessive production of ROS damages the mitochondria depriving cells of ATP.
ATP-depleted cells switch from apoptosis to necrosis since apoptosis is strictly
energy driven. Apoptosis is considered advantageous because the apoptotic
cells are eliminated by phagocytosis, preventing the release of intracellular
4

contents and the consequent damage to the surrounding tissues, as it occurs
during necrosis (Troyano et al., 2001).

The CNS is more vulnerable to OS than other tissues. It has been shown that
CNS is predisposed to OS due, among other things, to its exceptionally active
oxidative metabolism that generates relatively high levels of intracellular
superoxide (Bast et al., 1991). Also, low levels of antioxidant defenses, the
presence of highly unsaturated lipids, and elevated iron content in CNS cells
adds to the cellular vulnerability to oxidative damage. In recent years
experimental evidence has accumulated suggesting that OS is a major player in
the pathogenesis of inflammatory demyelination. As reviewed by Bizzozero
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(2009), a number of findings support the critical role of ROS in MS. These
include (1) the presence of the lipid peroxidation products in the CSF and plasma
of MS patients, (2) reduced plasma levels of antioxidants and antioxidant
enzymes in MS, (3) low levels of antioxidants like glutathione (GSH), αtocopherol and uric acid in MS plaques, (4) the damage to mitochondrial DNA in
active chronic plaques and (5) the effectiveness of various antioxidant treatments
at ameliorating EAE. The above studies clearly suggest that oxidative damage
has a causal role in the development of tissue injury in demyelinating disorders.
While MS and EAE were initially considered to be exclusively demyelinating
disorders, studies in the last decade have provided clear evidence that axonal
damage and neuronal cell death occur in these diseases (Meyer et al., 2001;
Aktas et al., 2007. Further, neuronal damage in MS correlates with clinical
disability (Meyer et al., 2001; Aktas et al., 2007) better than with demyelination.
Neuronal cell death can be triggered in many stressors. One of them is GSH
depletion, which is a characteristic feature of MS and EAE (Smerjac and
Bizzozero, 2008; Zheng and Bizzozero, 2010a,b; Dasgupta and Bizzozero, 2011,
Meyer et al., 2001). In this dissertation, I used specific GSH-depleted neuronal
cultures as a model of cell death to study the mechanistic aspects of apoptosis
and necrosis that may be happening in EAE.
1.3 Protein carbonylation and cell death
Proteins are abundant cellular components that are highly susceptible to
oxidation. Although the protein backbone and the side chains of most amino
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acids may undergo oxidation, the direct metal-catalyzed introduction of aldehyde
or ketone functional groups into proline, arginine, lysine and threonine (i.e.
carbonylation) constitutes the major and most common oxidative alteration in
aging (Berlett and Stadtman, 1997), EAE (Zheng and Bizzozero, 2010a) and MS
(Bizzoero et al., 2005). Another alteration that generates carbonyl groups is
through a non-oxidative pathway where the nucleophilic centers in cysteine,
histidine or lysine react with reactive carbonyl species (RCS) derived from
oxidized lipids such as 4-hydroxynonenal (4-HNE), malondialdehyde (MDA) and
acrolein (ACR), or oxidized carbohydrates such as glyoxal and methylglyoxal
(Figure 3). In some instances, rapid decomposition of hydroperoxides of valine
and leucine can also result in protein carbonyl formation (Bizzozero, 2009).
Because carbonyls are relatively difficult to induce compared to other oxidative
modifications of proteins (e.g. oxidation of thiols), they are normally detected
under

more

severe

(e.g.

neuroinflammation)

and

prolonged

(e.g.

neurodegeneration) OS conditions (Shacter, 2000). Our laboratory has recently
found increased levels of protein carbonyls in both white matter and gray matter
tissue of MS patients (Bizzozero et al., 2005) and in the spinal cord and
cerebellum of EAE rats and mice (Smerjac and Bizzozero, 2008; Zheng and
Bizzozero, 2011; Dasgupta and Bizzozero, 2011), indicating that protein
carbonylation is a factor present in inflammatory demyelinating disorders.
Protein carbonyls are believed to be toxic and might lead to cell death (Burcham
and Fontaine, 2001). In this dissertation I studied whether or not inhibiting protein
carbonylation has any consequence on the apoptosis of GSH-depleted neurons.
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1.4 Protein carbonylation, protein aggregation and cell death
Protein aggregates are supra-molecular assemblies of misfolded, oxidized and
damaged proteins that accumulate within cells. The presence of protein
aggregates is typically considered undesirable because they are largely
associated with cellular toxicity (Johansson et al., 2012) and neuronal apoptosis
(Estus et al., 1997; Zhu et al., 2000). Recently, protein aggregation has been
implicated in the pathophysiology of many neurodegenerative diseases such as
Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD)
and amyotrophic lateral sclerosis (ALS) (Trzesniewska et al., 2004; Hachiya et
al., 2008) and therefore became a subject of considerable investigation.
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It is noteworthy that while protein aggregates are toxic to many cell types, a
cytoprotective role in cancer cells has also been observed (Johansson et al.,
2012). The accumulation of protein aggregates is triggered by many factors. For
example, in AD the production of beta amyloid proteins triggers protein
aggregation in neurons leading to cytotoxic responses (Nilsberth et al., 2001;
Etienne et al., 2007). Other factors may include the overproduction of partially
misfolded, carbonylated and damaged proteins, which after reaching high levels,
cross-link and interact with each other to become a part of protein aggregates.
Oxidized proteins have been demonstrated to induce changes in the tertiary
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structure of proteins followed by exposure of hydrophobic domains that tend to
aggregate if they are not degraded rapidly (Grune and Davies, 1997).
The proteolytic machinery in cells continuously degrades damaged and
aggregated proteins to keep them at basal non-toxic levels and maintain
homeostasis. Despite proteasomes target the majority of damaged proteins by
recognizing increased hydrophobicity, some oxidized and aggregated proteins
are degraded by other systems. The proteolytc systems include proteasomes (in
cytosol and nucleus), cathepsins and other acid proteases in lysosomes or
autophagosomes (in cytosol), lon-proteases (in mitochondria) and calpain (in
cytosol). All of these proteases convert damaged proteins into small peptides
(Grune et al., 2001) that are further cleaved to amino acids by amino- and
carboxy-peptidases (Figure 4).
Proteasomes are large barrel shaped protein complexes that degrade
carbonylated proteins independent of ubiquitin and ATP (Divald and Powell,
2006). Moderately oxidized proteins are selectively recognized and degraded by
proteasomes while the susceptibility of heavily oxidized and cross-linked proteins
to proteasomal hydrolysis is much lower (Grune and Davies, 1997). Calpain also
preferentially degrades carbonylated proteins over the non-carbonylated
counterparts (Troncoso et al., 1995) and induces alterations in cell signaling. For
example calpain cleaved carbonylated apoptosis inducing factor translocates
from mitochondria to nucleus to trigger caspase dependent apoptotic pathway
(Norberg et al., 2010).
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Heavily oxidized proteins are targeted for lysosomal degradation or autophagy
while protein aggregates rely only on autophagy for their clearance. Most protein
aggregates are degraded by chaperone-mediated autophagy while aggregates
containing ubiquitinated proteins are removed by selective autophagy. Clearance
of protein aggregates by authophagy is called aggrephagy (Lamark and
Johansen, 2012). Proteasome failure or loss of aggrephagy (impairment in
autophagy) or both may result in the accumulation of degradation resistant
protein complexes. Currently, the formation of large protein aggregates is
considered cytoprotective (Arrastate et al., 2004; Kopioto, 2000) or less cytotoxic
than the small microaggregates dispersed within the cell (Arrastate et al., 2004;
Lamark and Johansen, 2012).
Protein carbonyls are known to trigger protein aggregation both in vitro and in
yeast cells, thereby compromising cellular viability (Mirzaei and Regneir, 2008).
Indeed, carbonylated proteins are highly enriched in protein aggregates in
prokaryotes (Maissonneuve et al., 2008) and in juxta-nuclear protein aggregates
called aggresomes in yeast cells (Mirzaei and Regneir, 2008). Yet, despite this
evidence, little is known about the relationship between protein carbonylation and
aggregate formation in mammalian cells undergoing OS. Furthermore, since
oxidized and cross-linked protein aggregates may inhibit the proteasome and
progressively increase protein aggregation (Grune et al., 2005), it is likely that
carbonylation and protein aggregation might be mutually responsible for
aggregation-associated proteotoxicity. In this dissertation, I used classical protein
aggregate inhibitors to determine the cause-consequence relationship between
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protein carbonylation and protein aggregation and their role in neuronal cell
death triggered by GSH depletion.
1.5 Hypothesis and goals of the study
Based on reports from the scientific literature and previous studies in our
laboratory,

I

hypothesize

that

carbonylated

proteins,

formed

as

a

consequence of oxidative stress and/or decrease proteasomal activity,
promote protein aggregation to mediate neuronal apoptosis in vitro and in
the spinal cord of EAE mice (Figure 5). The major goals of the study were
1) To characterize cell death in EAE and determine if protein carbonylation
and protein aggregation are related to neuronal apoptosis.
2) To determine if protein carbonylation, protein aggregation and cell death
are also associated in GSH-depleted cultured neurons.
3) To investigate the causal role of protein carbonylation and protein
aggregation in cell death.
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1.6 Significance
In this dissertation, I will show that protein carbonylation and protein aggregation
are linked to cell death in EAE. Further, protein carbonylation and aggregation
precedes neuronal apoptosis in GSH-depleted cultured neurons. In the same
system, Carbonyl scavengers and protein aggregation inhibitors prevent
neuronal cell death. These novel data will serve as the basis for developing novel
therapeutic strategy by either scavenging protein carbonyls and protein
aggregates or both, or by stimulating the removal of oxidized proteins and protein
aggregates. Future studies would test the effect of protein aggregate inhibitors in
EAE to determine the role of protein aggregation in neuronal death during the
disease progression. Furthermore, since OS, protein aggregation and neuronal
cell death has been observed in PD, AD and ALS (Ross and Poirier, 2004),
eliminating protein carbonyls and/or protein aggregates could be helpful in
providing neuroprotection in these diseases as well.
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2. Increased carbonylation, protein aggregation and apoptosis in the spinal
cord of mice with experimental autoimmune encephalomyelitis

Anushka Dasgupta1, Jianzheng Zheng1, Nora I. Perrone-Bizzozero2 and Oscar
A. Bizzozero1*

1

Deptartment of Cell Biology and Physiology and 2Department of Neurosciences,

University of New Mexico - Health Sciences Center, Albuquerque, New Mexico.

Abbreviations used: APC, adenomatous polyposis coli protein; DPI, days postimmunization; DNP, 2,4-dinitrophenyl; DNPH, 2,4-dinitrophenylhydrazine; EAE,
experimental autoimmune encephalomyelitis; GFAP, glial fibrillary associated
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2.1 ABSTRACT
Previous work from our laboratory implicated protein carbonylation in the
pathophysiology of both multiple sclerosis (MS) and its animal model
experimental autoimmune encephalomyelitis (EAE). Subsequent in vitro studies
revealed that the accumulation of protein carbonyls, triggered by glutathione
deficiency or proteasome inhibition, leads to protein aggregation and neuronal
cell death. These findings prompted us to investigate if their association can be
also established in vivo. In this study, we characterized protein carbonylation,
protein aggregation and apoptosis along the spinal cord during the course of
myelin-oligodendrocyte glycoprotein (MOG)35-55 peptide-induced EAE in C57BL/6
mice. The results show that protein carbonyls accumulate throughout the course
of the disease, albeit by different mechanisms: increased oxidative stress in
acute EAE and decreased proteasomal activity in chronic EAE. We also show a
temporal correlation between protein carbonylation (but not oxidative stress) and
apoptosis. Furthermore, carbonyl levels are significantly higher in apoptotic cells
than in live cells. A high number of juxta-nuclear and cytoplasmic protein
aggregates containing the majority of the oxidized proteins are present during the
course of EAE. The LC3-II/LC3-I ratio is significantly reduced in both acute and
chronic EAE indicating reduced autophagy and explaining why aggresomes
accumulate in this disorder. Altogether, our data suggest a link between protein
oxidation and neuronal/glial cell death in vivo and also demonstrate impaired
proteostasis in this widely used murine model of MS.
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2.2 INTRODUCTION
Experimental autoimmune encephalomyelitis (EAE) is an animal model of
multiple sclerosis (MS) that is routinely employed to study the mechanistic basis
of disease and to test therapeutic approaches (Gold et al., 2000). Both disorders
are characterized by CNS inflammation, demyelination, axonal degeneration, and
various degrees of oligodendrocyte and neuronal cell death (Luccinetti et al.,
1996; Kornek and Lassmann, 1999, Kuerten et al., 2007). In recent years,
several laboratories have obtained experimental evidence indicating that
oxidative stress is a major player in the pathogenesis of inflammatory
demyelination (Gilgun-Sherki et al., 2004; Bizzozero, 2009; Haider et al., 2011).
Severe and/or prolonged oxidative stress conditions does lead to the nonenzymatic modification of specific amino acid residues resulting in the
introduction of aldehyde or ketone functional groups (a.k.a. carbonylation)
(Stadtman and Berlett, 1997). Thus, it is not surprising that large amounts of
carbonylated proteins accumulate within CNS cells in many neurodegenerative
disorders (Ferrante et al., 1997; Floor and Wetzel, 1998; Aksenov et al., 2001;
Perluigi et al., 2005) as well as in neuroinflammatory disorders like MS
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(Bizzozero et al., 2005) and EAE (Smerjac and Bizzozero, 2008; Zheng and
Bizzozero, 2010a). However, the build-up of oxidized and other misfolded
proteins is due not only to an increase in the rate of protein oxidation but also to
their reduced proteolytic removal via the proteasome (Shringarpure et al., 2001;
Divald and Powell, 2006). In fact, impaired proteasomal activity has been
demonstrated in disorders where carbonylated proteins accumulate, including
Alzheimer’s disease (Keller et al., 2000), Parkinson’s disease (McNaught et al.,
2003), Huntington’s disease (Seo et al., 2004) and more recently in MS (Zheng
and Bizzozero, 2011) and EAE (Zheng and Bizzozero, 2010b; Zheng et al.,
2012).
There is a substantial amount of data showing that the presence of carbonyl
groups causes major changes in protein structure and function (Fucci et al.,
1983; Starke et al., 1987; Dalle-Donne et al., 2001), which results in the loss of
cell viability (England et al., 2004; Magi et al., 2004). In addition, carbonylation
brings about the formation of protease-resistant protein aggregates, which are
considered highly toxic and can mediate cell death (Nyström, 2005; Maisonneuve
et al., 2008b). Indeed, we have recently shown that protein carbonylation,
aggregation and cell death are linked during neuronal apoptosis triggered by
glutathione deficiency (Dasgupta et al., 2012). These findings and the fact that
both protein oxidation (Smerjac and Bizzozero, 2008; Zheng and Bizzozero,
2010a) and neuronal/oligodendrocyte apoptosis has been observed in EAE
(Meyer et al., 2001; Das et al., 2008), prompted us to investigate if their
association can be also established in vivo. In this study, and as a first step to
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demonstrate such relationship, we measured the extent of protein carbonylation,
protein aggregation and apoptosis along the spinal cord of mice with acute and
chronic EAE. The results show for the first time (1) a temporal correlation
between protein carbonylation (but not oxidative stress) and apoptosis, (2) an
increased accumulation of carbonyl in apoptotic cells, (3) the presence in EAE of
protein aggregates containing the majority of the oxidized proteins, and (4) a
reduced autophagy in both acute and chronic EAE, which suggests impaired
proteostasis in this murine model of MS. A preliminary account of these findings
has been presented in abstract form (Dasgupta and Bizzozero, 2011).
2.2 MATERIAL AND METHODS
Induction of Experimental Autoimmune Encephalomyelitis (EAE)
Housing and handling of the animals as well as the euthanasia procedure were in
strict accordance with the NIH Guide for the Care and Use of Laboratory
Animals, and were approved by the Institutional Animal Care and Use
Committee. Eight-week-old female C57BL/6 mice were purchased from Harlan
Bioproducts (Indianapolis, IN) and housed at the UNM-animal resource facility.
EAE was induced by active immunization with MOG35-55 peptide (AnaSpec, San
Jose, CA) as described in our previous study (Zheng and Bizzozero, 2010a).
Animals were weighed and examined daily for the presence of neurological
signs. Acute disease was defined as having maximal neurological symptoms of
EAE without any improvement for at least three consecutive days while chronic
EAE was operationally defined as animals that remain in the stationary phase of
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the disease for 30 days. Age-matched control animals for acute EAE (control
young) and chronic EAE (control old) consisted of mice injected with complete
Freund’s adjuvant alone (i.e. without the MOG peptide). EAE and control mice
were euthanized by decapitation, and the spinal cord was rapidly removed and
divided into cervical, thoracic and lumbar regions. Sections were either fixed with
methacarn (methanol : chloroform : acetic acid, 60 : 30 : 10 by vol) or
homogenized in PEN buffer (20 mM sodium phosphate, pH 7.5, 1 mM EDTA,
and 0.1 mM neocuproine) containing 2 mM 4,5 dihydroxy-1,3 benzene disulfonic
acid and 1 mM dithiothreitol. Protein homogenates were stored at -80°C until
use. Protein concentration was assessed with the Bio-Rad DCT™ protein assay
(Bio-Rad Laboratories; Hercules, CA) using bovine serum albumin as a standard.
For GSH determination, homogenates were prepared in PEN buffer without
reducing agents and were processed immediately as described below.
Determination of GSH and lipid-peroxidation products
GSH levels were determined using the enzymatic recycling method (Shaik and
Mehvar, 2006). Briefly, proteins from spinal cord homogenates were precipitated
with 1% sulfosalicylic acid and removed by centrifugation at 10,000g for 15min.
Aliquots of the supernatant were then incubated with 0.4U/ml glutathione
reductase, 0.2mM NADPH, and 0.2mM 5,5’-dithiobis-(2-nitrobenzoic acid) in 1ml
of 0.2M sodium phosphate buffer pH 7.5 containing 5mM EDTA. The rate of
appearance of the thionitrobenzoate anion was measured spectrophotometrically
at 412 nm. [GSH] was calculated by interpolation on a curve made with
increasing concentrations of GSSG (0.1-10nmol).
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Lipid peroxidation was estimated as the amount of thiobarbituric acid reactive
substances (TBARS) (Okawa et al., 1979). Briefly, aliquots from the spinal cord
homogenates were suspended in 10% (w/v) trichloroacetic acid containing 1%
(w/v) thiobarbituric and 0.05% (w/v) butylated hydroxytoluene. Samples were
incubated for 20 min at 90°C. Aggregated material was removed by
centrifugation at 10,000g for 15 min and the absorbance of the supernatant was
measured at 532 nm. The amount of TBARS was calculated using a standard
curve prepared with 1,1,3,3-tetraethoxypropane.
Proteasome and calpain activity
The chymotrypsin-like activity of the 20S proteasome in the spinal cord
homogenates was determined using a fluorescence assay (Rodgers and Dean,
2003). Briefly, 50µg protein was incubated for up to 2h at 25ºC with 50 µM of the
7-aminomethyl-4-coumarin (AMC)-labeled peptide Suc-Leu-Leu-Val-Tyr-AMC in
the absence or presence of 10µM β-clasto-lactacystin-lactone (Enzo Life
Sciences, Plymouth Meeting, PA). The proteasome activity was calculated as the
difference in fluorescence intensity at 460 nm between the samples without and
with inhibitor using excitation wavelength of 380nm. Calpain activity was also
determined with a fluorescence assay using the substrate Suc-Leu-Leu-Val-TyrAMC in 100mM KCl, 10mM CaCl2, 25mM Hepes buffer pH 7.5, and carrying out
the incubation in the absence or presence of 40µg/ml calpeptin (Hassen et al.,
2006).
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Oxyblot analysis
Protein carbonyl groups were measured by oxyblot analysis as described earlier
(Smerjac and Bizzozero, 2008). In brief, proteins (5µg) were incubated with 2,4dinitrophenylhydrazine (DNPH) to form the 2,4-dinitrophenyl (DNP) hydrazone
derivatives. Proteins were separated by electrophoresis and blotted to
polyvinylidene difluoride membranes. DNP-containing proteins were detected
using rabbit anti-DNP antiserum (1:500) and horseradish peroxidase-conjugated
goat anti-rabbit IgG antibody (1:2,000). Blots were developed by enhanced
chemiluminescence using the Western Lightning ECL™ kit from Perkin-Elmer
(Boston, MA). Films were scanned in a Hewlett Packard Scanjet 4890 and the
images were quantified using the NIH Image 1.63 imaging analysis program. The
intensity of each lane on the film was normalized by the amount of coomassie
blue staining in the corresponding lane.
Immunohistochemistry
Tissue specimens were fixed overnight in methacarn and then embedded in
paraffin. Tissue was cross-sectioned (3-µm thick) and mounted on Vectabond™treated

slides

(Vector

Laboratories,

Burlingame,

CA).

Sections

were

deparafinized with xylenes and a graded alcohol series, and then rinsed with
phosphate-buffered saline (PBS) solution for 10 min. Apoptosis was detected
using Click-iT® TUNEL Assay kit (Invitrogen). For carbonyl staining, sections
were incubated for 15 min with 1 mg/ml DNPH prepared in 1N HCl to convert
carbonyl groups into DNP-hydrazones. Sections were rinsed three times with
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PBS, blocked with 10% (v/v) normal goat serum and incubated overnight with
rabbit anti-DNP antibody (1:1000) (Sigma, St Louis, MO). After removing the
primary antibody with 0.1% Triton X-100 in PBS, sections were incubated for 3h
with Alexa Fluor® 647 goat anti-rabbit antibody (1:200, Molecular Probes,
Eugene, OR). Sections were rinsed twice with PBS, and then mounted using
DPX. Images were captured with a Zeiss 200m microscope (Carl Zeiss
MicroImaging Inc., Thornwood, NY) equipped with a Hamamatsu C4742-95
digital camera (Hamamatsu Corp., Bridgewater, NJ).
For double immunofluorescence, DNPH-treated sections were incubated with the
corresponding primary antibody, washed with PBS and followed by incubation
with fluorescent secondary antibodies (Alexa Fluor® 647, 1:200, Molecular
Probes). After washing, the sections were stained using Click-iT® TUNEL Assay
kit (Invitrogen Corp., Carlsbad, CA), rinsed with PBS and mounted using DPX.
The various cell types were detected by using antibodies against GFAP (1:250,
mouse monoclonal; Sigma), adenomatous polyposis coli protein C-terminal
(1:100, mouse monoclonal, Chemicon, Temecula, CA) and NeuN (1:200, mouse
monoclonal, Chemicon) with corresponding secondary antibody conjugated to
Alexa Fluor® 488.
For protein aggregation staining, methacarn fixed and paraffin embedded tissue
sections were deparafinized and hydrated followed by washing with PBS.
Samples were then incubated for 30 minutes with ProteoStat® Protein
Aggregation Assay solution (Enzo Life Sciences) and destained using distilled
water for 5 hours. Cellular nuclei were stained with DAPI (40ng/ml, Sigma).
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Stained sections were mounted using 1,4-diazabicyclo[2.2.2]octane in polyvinyl
alcohol (Sigma) as antifading agent.
Determination of autophagy index
Proteins (7.5 µg) were separated by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis on 15% gels and blotted to polyvinylidene difluoride membranes.
LC3-I (18 kDa) and LC3-II (16 kDa) were detected using rabbit anti-LC3
antiserum (1:1000, Sigma) and horseradish peroxidase-conjugated goat antirabbit

IgG

antibody

(1:2,000).

Blots

were

developed

by

enhanced

chemiluminescence as described above. The LC3-II/LC3-I ratio was determined
by scanning densitometry of the films.
Protein aggregation assay
Assessment of protein aggregation was carried out as described by
Maisonneuve et al., (2008a) with minor modifications. Spinal cord homogenates
prepared in PEN buffer containing 1mM dithiothreitol and 150mM NaCl were
centrifuged at 20,000xg for 30 min at 4°C. The pellets were then extracted with
the same buffer containing 1% Triton X-100. Samples were kept on ice for 15
min and then centrifuged at 20,000xg for 30 min at 4°C. The final pellet, which
contains some cytoskeleton structures but mostly aggregated proteins, was
processed for oxyblot analysis as described above.
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Statistical analysis
Results were analyzed for statistical significance with student t-test using
GraphPad Prism® program (GraphPad Software incorporation, San Diego, CA).
2.3 RESULTS
Characteristic of mice with acute and chronic EAE
EAE in female C57BL/6 mice was induced by active immunization with MOG35-55
peptide as described under Materials and Methods. Symptoms were graded
according to the following scale: 0, no symptoms; 1, tail weakness; 1.5, clumsy
gait; 2, hind-limb paresis; 2.5, partial hind-limb dragging; 3, hind-limb paralysis;
3.5, hind-limb paralysis with fore-limb paresis; 4, complete paralysis; and 5,
moribund. In this EAE model, neurological symptoms begin at 14 days postimmunization (DPI) (i.e. 7 days after the boost with MOG peptide) reaching a
peak at 30 DPI, and most animals remain ill throughout the entire experimental
period (60 DPI). Acute disease was defined as having maximal neurological
symptoms of EAE without any improvement for at least three consecutive days.
At this stage the spinal cord pathology is characterized by infiltration of
inflammatory cells, mostly within the white matter and meninges. Chronic EAE
was defined arbitrarily as animals that remain in the stationary phase of the
disease for 30 days (60 DPI). At this stage there is very low perivascular and
parenchymal inflammation, and almost no transmigration of inflammatory cells
into the spinal cord. CFA-injected animals, which were sacrificed at 30 DPI
(control young) and 60 DPI (control old), did not exhibit any neurological sign or
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spinal cord pathology. For the present study we analyzed a total of 29 animals: 6
control-young, 11 acute EAE (clinical scores ranging from 1.0-3.5), 6 control-old
and 6 chronic EAE (clinical scores ranging from 0.5-3.5) (Fig. 1a).
Increased neuronal and glial apoptosis in the spinal cord of mice with
acute and chronic EAE
Using TUNEL staining we first measured the number of cells undergoing
apoptosis in different spinal cord regions (cervical, thoracic and lumbar) during
the course of EAE. As depicted in Fig. 1, the total number of apoptotic cells in the
spinal cord of mice with acute EAE (panel b) was slightly higher than that with
chronic EAE (panel c). In both cases, the lumbar section showed the highest
number of apoptotic cells followed by the thoracic and cervical sections. These
findings are in agreement with the notion that the extent of spinal cord lesions
increases caudally (Müller et al., 2000). Similar results were obtained using
active caspase-3 as a marker of apoptosis (data not shown).
Double staining of the lumbar spinal cord sections of acute EAE mice for TUNEL
and cell-specific markers identified apoptotic cells as oligodendrocytes (48%),
neurons (27%) and astrocytes (15%) (Fig. 2a,b). The identity of the remaining
apoptotic cells (probably microglia and lymphocytes) was not determined. A
similar distribution was found in chronic EAE animals, where 45%, 20% and 13%
of the apoptotic cells were identified as oligodendrocytes, neurons and
astrocytes, respectively. Stereological analysis of the same spinal cord region
revealed that there is 27% neuronal loss, 15% oligodendrocyte loss and 36%

25

increase in the number of astrocytes (astrocytosis) in acute EAE (Fig. 2c). In
chronic EAE, neuronal and oligodendrocyte deficits are 29% and 21%,
respectively, while astrocyte number is almost unchanged (Fig. 2d).
Protein carbonylation, and not oxidative stress, correlates with apoptosis
As shown in Fig. 3a, GSH levels are reduced in all regions of the spinal cord of
mice with acute EAE, with the largest decline (~46%) found in the lumbar section.
In contrast, normal GSH concentrations are present in all the spinal cord areas of
animals with chronic EAE (Fig. 3b). This data is consistent with a weakened
cellular antioxidant defense system in acute EAE where inflammation is elevated.
In agreement with the GSH data, levels of TBARS, a marker of lipid peroxidation,
are elevated in all spinal cord segments of acute EAE (Fig. 3c) but not chronic
EAE mice (Fig. 3d). Certainly, there is an almost perfect inverse relationship
between GSH and TBARS levels throughout the length of the spinal cord. In
contrast to lipid peroxidation, the amount of protein carbonyls is augmented in
both acute EAE (Fig. 4a) and chronic EAE spinal cord (Fig. 4b) with the highest
increase found in the lumbar area. Since protein carbonyls are not eliminated by
enzymatic reduction to the corresponding alcohols (Bizzozero, 2009), the
accumulation of protein carbonyls in chronic EAE in the absence of significant
oxidative stress is most likely due to impaired proteolytic removal via the
chymotrypsin-like activity of 20S proteasome (Ferrington et al., 2005). Indeed,
this proteosomal activity, measured with a fluorogenic peptide substrate, was
found normal in acute EAE but greatly decreased in all spinal cord regions of
chronic EAE mice (Fig. 4c,d).
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Apoptotic cells contain higher levels of protein carbonyls
Since protein carbonylation and cell death shows a similar temporal pattern, we
sought to investigate if there is a spatial relationship between these two
parameters as well. To this end, spinal cord sections were double stained with
DNPH for carbonyls and TUNEL for apoptosis. Co-localization studies of
carbonyls and annexin-V, a late marker in the apoptotic pathway, were not
possible since sections for carbonyl detection had to be fixed in methacarn,
which dissolves membrane phospholipids. Fig. 5 shows that apoptotic (TUNEL
positive) cells are stained intensely with DNPH. Since this reagent also stains cell
nuclei, likely due to its reactivity towards DNA oligonucleotides (Luo and Wehr,
2009), only the fluorescence present in the cytoplasm was quantified. As
depicted in panel c, the fluorescence intensity in the cytoplasm of apoptotic cells
from the lumbar spinal cord region of mice with acute EAE is ~ 2 times higher
than that of non-apoptotic cells.
Carbonyls accumulate in all the major cell types of EAE spinal cord
Carbonyl levels in the various CNS cell types were determined by double-label
immunofluorescence using antibodies against NeuN, APC and GFAP to identify
neurons, oligodendrocytes and astrocytes, respectively. Carbonyl intensity in the
control lumbar spinal cord region is the highest in astrocytes (150.7 ± 8.3)
followed by oligodendrocytes (94.9 ± 6.7) and neurons (21.0 ± 1.3) (Fig 6). In
acute EAE, carbonyl intensity in astrocytes, oligodendrocytes and neurons
increase 2.8-, 2.1- and 4.3-fold, respectively. This suggests the occurrence of
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different oxidative environments and/or proteasome activities in the various cell
types.
The number of large protein aggregates is also increased in EAE.
Experiments were also conducted to determine the possible association between
protein aggregation and cell death. Unfortunately, simultaneous staining for
TUNEL and protein aggregation (ProteoStat®) was not possible due to the
overlapping emission spectrum of the dyes in the corresponding kits.
Nonetheless, we found a large increase in the number of protein aggregates,
both juxta-nuclear (aggresomes) and cytoplasmic, in the lumbar spinal cord of
mice with acute and chronic EAE as compared to controls (Fig. 7a,b).
Furthermore, in acute EAE, linear regression curves predict a positive
relationship between all three: protein carbonylation (r2 = 0.97), protein
aggregation (r2=0.83) and cell death (r2=0.88) and the clinical score (Fig. 7c). The
presence of aggresomes in EAE also suggested an impairment of autophagy, the
major degradation system responsible for the turnover of bulky cellular
components. Indeed, we found that the LC3-II/LC3-I ratio (a.k.a. autophagy
index) was significantly reduced in both acute and chronic EAE (Fig. 8).
Most carbonylated proteins are present in insoluble protein aggregates.
To determine if carbonylated proteins are part of protein aggregates, we
fractionated the spinal cord homogenates by differential centrifugation as
described by Maisonneuve et al., (2008a). This method is based on the large
sedimentation coefficient of protein aggregates relative to other cellular protein
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complexes and on their insolubility in high ionic-strength buffers containing the
non-denaturing detergent triton X-100. As shown in Fig. 9, carbonylated proteins
are highly enriched in the detergent insoluble protein fraction both in control and
EAE samples suggesting that, like in other aerobic systems (Maisonneuve et al.,
2008b), oxidized proteins are the major substrates for aggregation.
2.4 DISCUSSION
The present study reveals a positive correlation between protein carbonylation
(but not oxidative stress) and neuronal and glial apoptosis in the spinal cord of
EAE mice. As we found in glutathione-depleted or proteasome-inhibited cultured
neurons (Dasgupta et al., 2012), apoptotic cells have increased carbonyl
accumulation suggesting a cytotoxic role for this modification. We also describe
for the first time the presence of protein aggregates in EAE, which contain the
majority of the oxidized proteins. Furthermore, the build-up of these inclusion
bodies may result not only from augmented carbonylation but also from reduced
clearance by autophagy. The proteasome deficiency in chronic EAE and the
decrease of autophagy in both acute and chronic EAE clearly points to an
impaired proteostasis in this murine model of inflammatory demyelination. A
schematic model summarizing our experimental findings is shown in Fig. 10.
Consistent with previous studies (Pender et al., 1991; Akassoglou et al., 1998;
Anderson et al., 2008; Vogt et al., 2009; Toft-Hansen et al., 2011) we found
significant neuronal and oligodendrocyte loss in acute EAE along with
astrocytosis.

The

latter

involves

astrocyte
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activation,

hypertrophy

and

proliferation, which are considered to be a characteristic response to
inflammation or autoimmune injury of the CNS (Toft-Hansen et al., 2011).
Interestingly, the extent of neuronal and oligodendrocyte loss in chronic EAE is
similar to that in acute EAE despite apoptosis continues throughout the disease
process. While oligodendrocytes have some regenerating capacity that could
explain these findings (Arenella et al., 1984; Tripathi et al., 2010), the mitotic rate
of neurons is almost nil (Tripathi et al., 2010). Thus, we can conclude that (1) the
majority of neurons, and possibly oligodendrocytes, die during the acute
(inflammatory) phase and (2) only a small, yet significant, fraction of cell death
occurs by apoptosis. The notion that most cell death occurs early in the disease
is supported by the finding that calpain activity, a marker of both necrosis and
apoptosis (Guyton et al., 2005), is elevated in acute EAE but not in chronic EAE
(Fig. S1).
Like in most neurodegenerative disorders, oxidative stress is also a significant
player in the pathogenesis of inflammatory demyelination (Smith et al., 1999;
Gilgun-Sherki et al., 2004). At the peak of the disease, and concomitant with the
rise in inflammation, there is increased oxidative stress with the ensuing
depletion of cellular GSH and accumulation lipid peroxides and protein carbonyls.
There are several, and not mutually exclusive, reasons underlying the reduction
of GSH in acute EAE. These include (1) oxidation of GSH to glutathione disulfide
(GSSG); (2) conjugation of GSH with reactive α,β-unsaturated aldehydes derived
from lipid peroxidation (e.g. acrolein, 4-hydroxynonenal); (3) reduced cellular
uptake of cysteine, required for GSH synthesis, due to high levels of glutamate
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(Sagara and Schubert, 1998); (4) decreased activity of enzymes involved in the
GSH synthesis (e.g. glutathione synthetase) and/or recycling of GSSG via
glutathione reductase; and (5) diminished amount of NADPH, which is needed
for GSSG reduction. However, regardless of the mechanism responsible for the
decrease in low-molecular-weight thiols, GSH levels return to normal values in
the chronic phase of the disease as inflammation also subsides. As expected,
the amount of lipid peroxidation products is high in acute EAE and decreases to
normal levels in the chronic phase. In contrast, protein carbonyls are also
elevated in chronic EAE and likely the result of the lower proteasome proteolytic
activity in this stage of the disease. Thus, cell death in the spinal cord of EAE
mice exhibits a better temporal correlation with the build-up of oxidized proteins
than with oxidative stress. Furthermore, while carbonyls are also present in live
cells during the course of EAE, their levels are much higher in apoptotic cells
demonstrating a spatial correlation between these two parameters.
It is interesting to note that in both control and EAE spinal cord, astrocytes
contain the highest levels of carbonyls, followed by oligodendrocytes and
neurons. This result is not totally unexpected since astrocytes produce large
amounts of ROS (Keller et al., 1999) that could generate significant amounts of
carbonyls within these cells. Nonetheless, it was somewhat surprising to find that
the basal carbonyl staining in neurons and oligodendrocytes are significantly
lower, particularly when these two cell types are considered to be highly
susceptible to oxidative stress (Halliwell, 2006; Benarroch, 2009). Interestingly,
the notion that astrocytes are less sensitive to oxidative damage than other CNS
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cells has been recently challenged. It has been found that astrocytes in the
unperturbed mouse brain contain significantly lower levels of reduced glutathione
than neurons and oligodendrocytes (Miller et al., 2009). An alternative possibility
is that oligodendrocytes and neurons may have a more efficient proteolytic
machinery to remove oxidized proteins thus reducing the build up of carbonylated
proteins in these cells. Studies are underway to determine GSH and proteasome
levels in individual cells during the course of EAE.
Carbonylation is known to cause inappropriate inter- and intra-protein cross-links
as well as protein misfolding, which in turn results in the formation of highmolecular-weight aggregates (Grune et al., 1997; Mirzaei and Regnier, 2008). As
these aggregates get larger they precipitate, become resistant to proteolytic
degradation and reduce cell viability (Nyström, 2005; Maisonneuve et al., 2008a).
The precise relationship between protein aggregate formation and apoptosis, or
whether the aggregates are themselves cytotoxic is unclear. It has been recently
discovered that protein aggregates, as they form, sequester multiple preexistent
and newly synthesized proteins that have essential cellular functions and thus
are critical for cell survival (Olzscha et al., 2011). The presence in EAE tissues of
a significant number of cells containing large protein aggregates is noteworthy
and may be due not only to an increase in the amount of carbonylated proteins
but also to a deficient removal. In this regard, we found that autophagy, the major
mechanism for protein aggregate clearance (Son et al., 2012), is significantly
reduced in both acute and chronic EAE thereby explaining the presence of juxtanuclear protein aggregates throughout the disease. While it is tempting to
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speculate that these inclusion bodies contribute significantly to cell death, there is
some evidence suggesting aggresomes may instead provide a cytoprotective
function by sequestering the toxic, aggregated proteins (Tyedmers et al., 2010).
Some of the same studies also propose that the smaller protein aggregates are
the cytotoxic species. Thus, in the future, it will be important to determine the
size-distribution of protein aggregates during the course of the disease as we
may find that the presence of small rather than large aggregates correlates better
with the changes in pathology and disease activity. Indeed, the occurrence in
EAE of protein aggregates with a size smaller than those detected by
histochemical analysis is very likely since protein carbonyls, which are enriched
in the aggregates isolated by high-speed centrifugation, do not co-localize with
the ProteoStat-positive aggresomes and large cytoplasmic inclusion bodies.
Using neuronal cultures, we have recently found that a moderate depletion of
glutathione (GSH), similar to that observed in EAE (this study), leads to
increased protein carbonylation, protein aggregation and cell death, all of which
are temporally correlated (Dasgupta et al., 2012). Furthermore, several protein
carbonyl scavengers (hydralazine, histidine hydrazide and methoxylamine)
prevented protein aggregation and cell death, suggesting that during GSH
depletion oxidized proteins are critical for aggregate formation and cytotoxicity. In
that study, we also found that protein aggregates are not made of carbonylated
proteins exclusively since the cellular amount of oxidized species is roughly 1-2%
of that of the aggregates. However, protein carbonylation may expose
hydrophobic surfaces that can mediate aberrant interactions with other (non-
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oxidized) proteins, resulting in their functional impairment and sequestration as
was recently proposed for several cerebral proteopathies (Walker and LeVine,
2012). Preliminary studies in our laboratory also show that inhibition of protein
aggregation with Congo Red and 2-hydroxypropyl-β-cyclodextrin reduce
neuronal cell death induced by partial GSH depletion without affecting oxidative
stress or protein carbonylation, which suggests a direct link between protein
oxidation, protein aggregation and cell death (Dasgupta and Bizzozero,
unpublished results). In the future, it will be important to examine whether
carbonyl scavengers and aggregation inhibitors prevent or reduce cell death and
ameliorate disease activity in EAE. Interestingly, it has been recently found that
the reactive carbonyl scavenger hydralazine reduces disease activity in acute
EAE mice (Leung et al., 2011). Yet, while encouraging, these findings should be
interpreted with caution since hydralazine is also a potent antioxidant (Zheng and
Bizzozero, 2010) and it is well known that reduction of oxidative stress
ameliorates EAE (Marracci et al., 2002; Penkowa and Hidalgo, 2003; Hendricks
et al., 2004; Offen et al., 2004). Studies using carbonyl scavengers lacking
antioxidant and anti-inflammatory properties are thus needed to elucidate the role
of protein oxidation in inflammatory demyelination.
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Fig. 1 – Apoptosis along the
spinal cord is high in both acute
and chronic EAE – (a) Clinical
scores of animals used in the
study. (b, c) Number of apoptotic
cells determined by TUNEL
staining in the different spinal cord
regions (cervical, thoracic and
lumbar) of acute and chronic EAE
mice, respectively. A total of 5-8
non-consecutive
(30µm
apart)
3µm-thick sections per animal were
analyzed and averaged. Values
represent the mean ± SEM of 3
animals per experimental group.
Clinical scores (mean ± SEM) of
acute and chronic EAE mice were
2.2 ± 0.7 and 1.8 ± 0.7,
respectively. *p<0.05, **p<0.005,
***p<0.0005.
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Fig. 2 - Significant neuronal and glial apoptosis occurs in acute and
chronic EAE. (a) High-magnification, double-label immunofluorescence images
of lumbar spinal cord sections of acute EAE mice depicting an apoptotic neuron,
astrocyte and oligodendrocyte. Immunohistochemical detection of cellular
apoptosis was determined using TUNEL (green channel) and antibodies against
specific cell types (neurons: NeuN, astrocytes: GFAP, oligodendrocytes: APC).
(b) Number of TUNEL-positive cells in the lumbar spinal cord of acute and
chronic EAE mice that are identified as neurons, astrocytes and
oligodendrocytes. A total of 5 non-consecutive (30µm apart) 0.3µm-thick sections
per animal were analyzed and averaged. Values are the mean ± SEM of 3-6
animals per experimental group. Clinical scores (mean ± SEM) of acute and
chronic EAE mice were 2.2 ± 0.7 and 1.8 ± 0.7, respectively. Numbers on top of
the bars are the values expressed as percentage of TUNEL-positive cells. Note
that those numbers do not add up to 100% since there are other unidentified
apoptotic cells. (c, d) Average number of neurons, astrocytes and
oligodendrocytes per section in the lumbar spinal cord region of acute and
chronic EAE mice, respectively. Cells were identified using the same markers as
indicated above and DAPI staining. A total of 5 non-consecutive (30µm apart)
3µm-thick sections per animal were analyzed and averaged. Values represent
the mean ± SEM of 3 mice per experimental group. **p<0.005, ***p<0. 0005.
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Fig. 3 –Diminished GSH levels and increased lipid peroxidation are found
only in acute EAE. (a, b) GSH levels in the various spinal cord regions (cervical,
thoracic and lumbar) of acute and chronic EAE mice, respectively. Values
represent the mean ± SEM of 3-4 animals per experimental group. Clinical
scores (mean ± SEM) of acute and chronic EAE mice were 2.0 ± 0.5 and 1.7 ±
0.6, respectively. (c, d) TBARS levels in the different spinal cord regions of acute
and chronic EAE mice, respectively. Values represent the mean ± SEM of 3-5
animals per experimental group. Clinical scores (mean ± SEM) of acute and
chronic EAE mice were 2.3 ± 0.5 and 1.7 ± 0.6, respectively. *p<0.05, **p<0.005,
***p<0.0005.
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Fig. 4 - Protein carbonyls accumulate in both acute and chronic EAE. (a, b)
Protein carbonyl levels in the various spinal cord regions (cervical, thoracic and
lumbar) of acute and chronic EAE mice, respectively. (c, d) Proteasome
chymotrypsin-like activity in the different spinal cord regions of acute and chronic
EAE mice, respectively. Fl, fluorescence units. Values represent the mean ±
SEM of 3 animals per experimental group. Clinical scores (mean ± SEM) of acute
and chronic EAE mice were 2.2 ± 0.7 and 1.8 ± 0.7, respectively. *p<0.05,
**p<0.005.

43

Fig. 5 - Carbonylation levels are higher in apoptotic than in non-apoptotic
cells. (a) Double-label immunofluorescence images of lumbar spinal cord
sections from control and acute EAE mice. Carbonyls were detected by anti-DNP
labeling after derivatization with DNPH (red channel) and apoptotic cells were
identified by TUNEL staining (green channel). (b) High-magnification image
depicting a TUNEL-positive cell containing extensive carbonyl staining in the
cytoplasm. (c) Bar graph showing carbonyl levels in the cytoplasm of TUNELpositive cells (TPC) and TUNEL-negative cells (TNC) in the lumbar spinal cord
region of acute EAE mice. A total of 10 non-consecutive (30µm apart) 3µm-thick
sections per animal were analyzed and averaged. Values represent the mean ±
SEM of 5 animals per experimental group. Clinical scores (mean ± SEM) of acute
EAE mice were 2.3 ± 0.5. *p<0.05. Fl, fluorescence intensity.
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Fig. 6 - Carbonyls accumulate in all the major cell types present in the EAE
spinal cord. (a) Double-label immunofluorescence images of cells from the
lumbar spinal cord region of acute EAE mice depicting carbonyl staining in the
red channel (anti-DNP labeling after derivatization with DNPH) and cell type
markers in the green channel (NeuN for neurons, GFAP for astrocytes and APC
for oligodendrocytes). (b) Carbonyl content in different cell types in the lumbar
spinal cord of control and acute EAE mice. A total of 5-8 non-consecutive (30µm
apart) 3µm-thick sections per animal were analyzed and averaged. Values
represent the mean ± SEM of 5 animals per experimental group. Clinical scores
(mean ± SEM) of acute EAE mice were 2.3 ± 0.5. ***p<0.0005. Fl, fluorescence
intensity.
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Fig. 7 – The number of protein aggregates augments in both acute and
chronic EAE. (a) Representative images of lumbar spinal cord of control and
acute EAE mice stained with the ProteoStat® protein aggregation dye (red) and
DAPI (light blue) for nuclear identification. (b) Bar diagram showing the number
of large protein aggregates in cross-section of the lumbar spinal cord. A total of
9-15 non-consecutive (30µm apart) 3µm-thick sections per animal were analyzed
and averaged. Values represent the mean ± SEM of 3-5 animals per
experimental group. Clinical scores (mean ± SEM) of acute and chronic EAE
mice were 2.4 ± 0.5 and 2.5 ± 0.6, respectively. (c) Linear regression curves
predicting a positive relationship between protein carbonylation (PC, r2 = 0.97),
protein aggregation (PA, r2=0.83) and cell death (CD, r2=0.88) with the clinical
score. Each point represents the average of 2-3 EAE mice per experimental
group.
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Fig. 8 – Autophagy is impaired in both acute and chronic EAE. (a) A
representative western blot depicting the expression of LC3-I and its shorter and
lipidated form (LC3-II) in the spinal cord of control and EAE mice. (b) Authophagy
index (i.e. LC3-II/LC3-I expression) was determined by densitometric scanning of
the western blots. Values represent the mean ± SEM of 4-6 animals per
experimental group. Clinical scores (mean ± SEM) of acute and chronic EAE
mice were 3.0 ± 0.3 and 2.8 ± 0.5, respectively. *p<0.05, **p<0.005.
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Fig. 9 – Carbonylated proteins partition into the aggregated protein
fraction. Levels of protein carbonyls in the spinal cord homogenates and the
triton-insoluble aggregated protein fraction were quantified by oxyblot analysis.
Values are expressed as the percentage of total protein carbonyls present in the
aggregated protein fraction and represent the mean ± SEM of 3 animals per
experimental group. Clinical scores (mean ± SEM) of acute and chronic EAE
mice were 3.5 ± 0.0 and 2.2 ± 0.3, respectively. Note that the triton-insoluble
fraction, which has less than 20% of the protein present in the initial spinal cord
homogenate, contains between than 60%-70% of the protein carbonyls.
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Fig. 10 – Schematic diagram that incorporates the major findings of this
study. Carbonylated proteins accumulate in the spinal cord of both acute and
chronic EAE mice, albeit by different mechanisms: increased oxidative stress in
acute EAE and decreased proteasomal activity in chronic EAE. Augmented
protein carbonyl levels and diminished authophagy lead to the formation of
protein aggregates throughout the course of the disease. The occurrence of
small and/or large protein aggregates may be responsible for the increased
neuronal and glial apoptosis.
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SUPPLEMENTAL INFORMATION

Fig. S1- Calpain activity is increased only in acute EAE. (a, b) Calpain
activity in the different mouse spinal cord regions (cervical, thoracic, lumbar) in
acute and chronic EAE, respectively. FI, fluorescence intensity. Values represent
the mean ± SEM of 4-5 animals per experimental group. Clinical scores (mean ±
SEM) of acute and chronic EAE mice were 2.3 ± 0.5 and 2.7 ± 0.5, respectively.
*p<0.05, **p<0.005, **p<0.0005.
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3.1 ABSTRACT
While the build-up of oxidized proteins within cells is believed to be toxic, there is
currently no evidence linking protein carbonylation and cell death. In this study
we show that incubation of neuron-like PC12 (nPC12) cells with 50µM diethyl
maleate (DEM) leads to a partial and transient depletion of glutathione (GSH).
Concomitant with GSH disappearance there is increased accumulation of protein
carbonyls

(PCOs)

and

cell

death

(both

by

necrosis

and

apoptosis).

Immunocytochemical studies also revealed a temporal/spatial relationship
between carbonylation and cellular apoptosis. In addition, the extent of all three
PCO accumulation, protein aggregation and cell death augments if oxidized
proteins are not removed by proteasomal degradation. Furthermore, the
effectiveness of the carbonyl scavengers hydralazine, histidine hydrazide and
methoxylamine at preventing cell death identifies PCOs as the toxic species.
Experiments

using

well-characterized

apoptosis

inhibitors

place

protein

carbonylation downstream of the mitochondrial transition pore opening and
upstream of caspase activation. While the study focused mostly on nPC12 cells,
experiments in primary neuronal cultures yielded the same results. The findings
are also not restricted to DEM-induced cell death since a similar relationship
between carbonylation and apoptosis was found in staurosporin- and buthionine
sulphoximine-treated nPC12 cells. In sum, the above results show a causal
relationship between carbonylation and apoptosis of neurons undergoing
oxidative damage.
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3.2 INTRODUCTION
Many neurological disorders are characterized by severe and/or prolonged
oxidative stress conditions, which play a significant pathophysiological role
(Reynolds et al., 2007; Jomova et al., 2010). The major outcome of oxidative
stress is the irreversible damage of cell macromolecules by reactive oxygen
species (ROS). Proteins are the major target for oxidants as a result of their
abundance and their elevated reaction rate constants (Davies, 2005). Although
the polypeptide backbone and the side chains of most amino acids are
susceptible to oxidation, the non-enzymatic introduction of aldehyde or ketone
functional groups to specific amino acid residues (i.e. carbonylation) constitutes
the

most

common

oxidative

alteration

of

proteins

(Bizzozero,

2009).

Accumulation of protein carbonyls does not only occur but has also been
implicated in the etiology and/or progression of several CNS disorders, including
Alzheimer’s disease (Aksenov et al., 2001), Parkinson’s disease (Floor and
Wetzel, 1998), amyotrophic lateral sclerosis (Ferrante et al., 1997) and multiple
sclerosis (Bizzozero et al., 2005).
Carbonylation is believed to have deleterious effects on both protein function and
cell viability. However, while there is ample experimental evidence demonstrating
that the presence of carbonyl groups leads to changes in protein structure and
function (Fucci et al., 1983; Starke et al., 1987; Dalle-Donne et al., 2001), a direct
relationship between protein carbonylation and cell death has not been
conclusively established. The major problem lies on the difficulty to differentiate
the effect(s) of carbonylation from that of other protein modifications that occur
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simultaneously under oxidative stress conditions (e.g. oxidation of cysteine thiols,
nitration of tyrosine residues). Nonetheless, a number of studies have recently
surfaced suggesting a link between increased protein carbonylation and loss of
cell viability. For instance, carbonylation of critical glycolytic enzymes in etopsidetreated HL60 cells seems to decrease glucose utilization and cause cell death
(England et al., 2004), while oxidation of several chaperones has been
associated to apoptosis of irradiated HL60 human leukemia cells (Magi et al.,
2004). In addition, carbonylation may lead to the formation of large, proteaseresistant protein aggregates, which are considered highly cytotoxic (Nyström,
2005; Maisonneuve et al., 2008).
Because of the potential cellular toxicity that results from the accumulation of
carbonylated proteins, their intracellular levels are normally maintained very low
by proteolytic removal. Among the various cellular proteases, the 20S
proteasome, via it chymotrypsin-like activity and in an ATP-independent manner,
has been shown responsible for digesting oxidized proteins (Shringarpure et al.,
2003; Divald and Powell, 2006). Indeed, failure of this proteolytic system, as it
happens in many neurodegenerative disorders, results in the build up of oxidized
proteins that likely contributes cellular dysfunction and tissue damage (Rinaudo
and Piccinini, 2007).
In recent years, our laboratory has been investigating the mechanism of protein
carbonylation and the metabolic/cellular impact of increased protein oxidation in
inflammatory demyelinating disorders. We have found that protein carbonyls
accumulate in the CNS of patients with multiple sclerosis (Bizzozero et al., 2005)
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and of animals with experimental autoimmune encephalomyelitis (EAE) (Smerjac
and

Bizzozero,

2008;

Zheng

and

Bizzozero,

2010b).

Recent

immunohistochemical studies in the spinal cord of EAE mice have demonstrated
a positive correlation between carbonylation levels and neuronal/oligodendrocyte
apoptosis (Dasgupta and Bizzozero, 2011). Based on these findings we set up to
investigate whether a relationship, causal or otherwise, exists between protein
carbonylation and neuronal cell death in vitro. To this end, the concentration of
GSH in nerve growth factor (NGF)-treated PC12 cells or primary neurons was
reduced to levels similar to those found in the spinal cord of EAE animals. Under
these oxidative stress conditions, we discovered a close temporal/spatial
relationship

between

protein

carbonylation

and

apoptosis.

Experiments

combining GSH depletion, proteasome inhibition and carbonyl scavenging
strengthened the link between protein damage in the form of carbonyls and loss
of cell viability.
3.3 Material and Methods
Neuronal cultures and drug treatments
Rat adrenal medullary pheochromocytoma (PC12) cells were cultured on poly-Llysine-coated 6-well plates (BioCoat™, BD Biosciences, Bedford, MA) in RPMI1640 media containing 10% serum (7.5% donor horse and 2.5% fetal calf serum;
Sigma, St. Louis, MO) and an antibiotic/antimycotic mixture (Invitrogen Corp.,
Carlsbad, CA). Cells grown at 60-70% confluence were differentiated into a
neuronal phenotype by incubation with 100 ng/ml of NGF (Sigma) for either 1 or
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7 days. Primary neuronal cultures were established from cerebral cortices of
C57BL/6 mice and grown for 7 days as described by Harms et al. (2010). Cells
were treated with the GSH depletor diethylmaleate (DEM, Sigma) for 1-24 hours.
Control cells were left untreated after incubation with NGF. In some cases, DEMtreated cells were incubated with the proteasome inhibitors lactacystin (Enzo Life
Sciences, Plymouth Meeting, PA) and epoxomycin (Enzo) in the absence or
presence of various compounds including trolox (Sigma), hydralazine (Sigma),
methoxylamine (Sigma), z-histidine hydrazide (Peninsula Laboratories, San
Carlos, CA). Other drugs tested were the mitochondrial permeability transition
pore (MPTP) inhibitor cyclosporin A (Calbiochem; La Jolla, CA), the pan-caspase
inhibitor zVAD-fmk (Sigma), the apoptosis initiator staurosporine (Sigma) and the
GSH depletor buthionine sulfoximine (BSO) (Sigma). After incubation, cells were
homogenized in PEN buffer (20 mM sodium phosphate, pH 7.5, 1 mM EDTA,
and 0.1 mM neocuproine) containing 2 mM 4,5 dihydroxy-1,3-benzene disulfonic
acid and 1 mM dithiothreitol. For GSH determination, cells were homogenized in
PEN buffer without reducing agents and were processed immediately as
described below. Protein homogenates were stored at -80°C until use. Protein
concentration was assessed with the Bio-Rad DC™ protein assay (Bio-Rad
Laboratories; Hercules, CA) using bovine serum albumin as standard.
Determination of GSH and lipid-peroxidation products
GSH levels were determined using by enzymatic recycling method (Shaik and
Mehvar, 2006). Lipid peroxidation in the cell homogenates was estimated as the
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amount of thiobarbituric acid reactive substances (TBARS) (Ohkawa et al.,
1979).
Proteasome activity
The chymotrypsin-like activity of the 20S proteasome was determined in the cell
homogenates using a fluorescence assay (Rogers and Dean, 2003). Briefly,
50µg protein was incubated for 2h at 25ºC with 50 µM of the 7-aminomethyl-4coumarin (AMC)-labeled peptide Suc-Leu-Leu-Val-Tyr-AMC (Enzo) in the
absence or presence of 10µM β-clasto-lactacystin-lactone (Enzo). The
proteasome activity was calculated as the difference in fluorescence intensity at
460 nm between the samples without and with inhibitor using excitation
wavelength of 380nm.
Calpain activity
Calpain activity was also determined with a fluorescence assay using the
substrate Suc-Leu-Leu-Val-Tyr-AMC. In this case, incubation was carried out in
25mM Hepes buffer pH 7.5 containing 100mM KCl and 10mM CaCl2, in the
absence or presence of 10 µg calpeptin (Hassem et al., 2006).
Western blot and oxyblot
Proteins (5 µg) were separated by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis on 10% gels and blotted to polyvinylidene difluoride membranes.
Blots then were incubated overnight at 4°C with monoclonal (mAb) or polyclonal
antibodies (Ab) against spectrin (mAb, 1:2,000; Sigma), GAP-43 (Ab, 1:2,000, a
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gift from Dr. Perrone-Bizzozero), γ-enolase (Ab, 1:2000; Sigma), active caspase3 (mAb, 1:1,000; Cell Signaling, Danvers, MA), 20S proteasome α-subunit (mAb,
1:2,000; Enzo), 4-hydroxynonenal (4-HNE) (Ab, 1:1,000; Abcam, Cambridge,
MA), malondialdehyde (MDA) (Ab, 1:1,000; Abcam) and acrolein (ACR) (Ab,
1:1,000; Abcam). Membranes were rinsed three times in phosphate-buffered
saline (PBS) containing 0.05% Tween-20, and then incubated for 2h with the
appropriate horseradish peroxidase (HRP)-conjugated secondary antibody. Blots
were developed by enhanced chemiluminescence using the Western Lightning
ECL™ kit from Perkin-Elmer (Boston, MA).
Protein carbonyl groups were measured by oxyblot analysis as described earlier
(Smerjac and Bizzozero, 2008). In brief, proteins (5µg) were incubated with 2,4dinitrophenylhydrazine (DNPH) to form the 2,4-dinitrophenyl (DNP) hydrazone
derivatives. Proteins were separated by electrophoresis and blotted to
membranes as above. DNP-containing proteins were detected using rabbit antiDNP antiserum (1:500) and HRP-conjugated goat anti-rabbit IgG antibody
(1:2,000). Developed films were scanned in a Hewlett Packard Scanjet 4890 and
the images were quantified using the NIH Image 1.63 imaging analysis program.
The intensity of each lane on the film was normalized by the amount of
coomassie blue staining in the corresponding lane.
Immunohistochemistry
Cells, cultured on 12 mm round poly-lysine coated coverslips (BD BioCoat™)
were fixed with 4% paraformaldehyde for 20 min. For carbonyl staining, fixed
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cells were incubated for 15 min with 1 mg/ml DNPH prepared in 1N HCl to
convert carbonyl groups into DNP-hydrazones. Cells were rinsed with PBS,
blocked with 10% (v/v) normal goat serum and incubated overnight with rabbit
anti-DNP antibody (1:1000; Sigma). After removing the primary antibody with
0.1% triton-X-100 in PBS, slides were incubated for 3h with Alexa Fluor® 647
goat anti-rabbit antibody (1:100, Molecular Probes, Eugene, OR). Cells were
rinsed twice with 0.1% Triton X-100 in PBS. For double immunofluorescence
staining using Click-iT® TUNEL Assay kit (Invitrogen), DNPH-treated specimens
were

incubated

with

terminal

deoxynucleotidyl

transferase

and

dNTPs

conjugated to Alexa Fluor®488 azide, rinsed twice with 0.1% Triton X-100 in
PBS, once with PBS, and then mounted using DPX. Images were captured with
a Zeiss 200m microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY)
equipped with a Hamamatsu C4742-95 digital camera (Hamamatsu Corp.,
Bridgewater, NJ). Please note that images obtained using paraformaldehyde
and methacarn fixatives were similar (Supplemental Fig. 1). Incubation with
HCl did not affect the TUNEL staining (Supplemental Fig. 2). Damaged-nuclei
reacted with DNPH, therefore we titrated the DNPH intensity of the
cytoplasm for our study (Supplemental Fig. 3). Necrotic cells were identified on
the basis of morphological features such as swollen cell bodies with many holes
while apoptotic cells were identified by DNA fragmentation.
For NFH staining, fixed cells were incubated overnight with mouse anti-NFH
antibody (mAb, 1:250; Sigma) followed by a 3h-incubation with Alexa Fluor® 488
rabbit anti-mouse antibody (Ab, 1:100; Molecular Probes).
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Cell viability assays
For trypan blue exclusion assay, floating and adherent cells were diluted in PBS,
stained with 0.4% trypan blue for 5 min, and counted in a Nebauer
hemocytometer (Altman et al., 1993). Cell death was also determined by
measuring lactate dehydrogenase (LDH) activity on a 10µl-aliquot from the cell
supernatant using the LDH-cytotoxicity assay kit II (ABCAM, Cambridge, MA).
Protein aggregation assay
Cell homogenates prepared in PEN buffer containing 1mM dithiothreitol and
150mM NaCl were centrifuged at 20,000xg for 30 min at 4°C. The pellets were
then extracted with the same buffer containing 1% triton X-100. Samples were
kept on ice for 15 min and were centrifuged at 20,000xg for 30 min at 4°C. The
final pellet, which contains some cytoskeleton structures but mostly aggregated
proteins, was re-suspended in PEN buffer for protein determination.
Statistical analysis
Results were analyzed for statistical significance with student t-test using
GraphPad Prism® program (GraphPad Software incorporation, San Diego, CA).
3.4 RESULTS
Low doses of DEM causes partial and transient GSH depletion in neuronal
cells

60

PC12 cells were differentiated into a neuronal phenotype by incubation with NGF
for 24h. These cells, which we termed neuron-like PC12 or nPC12, developed
neurites that stained positive for neurofilament heavy chain (NFH) (Fig. 1a) and
expressed the neuron-specific markers α-spectrin, GAP-43 and γ-enolase (Fig.
1b). Reduction of intracellular GSH levels was attained with DEM. This
membrane-permeable electrophilic agent depletes intracellular GSH by directly
conjugating with GSH through glutathione-S-transferase (Buchmüller-Rouiller et
al., 1995), leading to mitochondrial production of reactive oxygen species (ROS)
and oxidative stress (Bizzozero et al., 2006). As shown in Fig. 2a, DEM dosedependently reduced the concentration of GSH in nPC12 cells. For this study, we
chose a concentration of 50µM DEM to achieve a reduction in GSH levels similar
to that observed in the spinal cord of EAE mice (Dasgupta and Bizzozero, 2011).
At 50µM DEM, GSH levels decreased progressively, reaching the lowest values
between 3h and 12h of incubation. By 24h, the concentration of GSH was back
to normal (Fig. 2b). Since the thioether linkage between GSH and DEM is
metabolically stable, the recovery of GSH levels at longer incubation times is
likely due to de novo synthesis of the tripeptide. Similar results were obtained in
more differentiated cells such as PC12 cells treated with NGF for 7 days (Fig. 2c)
and primary cortical neurons (Fig. 2d).
Protein carbonylation and GSH depletion are correlated in DEM-treated
nPC12 cells
Lipid peroxidation and protein oxidation were evaluated by measuring TBARS
and PCO levels, respectively. As shown in Fig 3a, TBARS levels do not change
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during the incubation of nPC12 cells with 50µM DEM, although the mean values
were higher at the peak of oxidative stress (3-12h). In contrast, the amount of
protein carbonyls increased progressively from 2h to 12h and then diminished
significantly by 24h of incubation (Fig. 3b). Again, similar results were obtained in
PC12 cells treated with NGF for 7 days and in primary cortical neurons (data not
shown).
Protein carbonyls are not eliminated by enzymatic reduction to the corresponding
alcohols (Bizzozero, 2009). Instead, they are removed by degradation via the
chymotrypsin-like activity of 20S proteasome (Ferrington et al., 2005). We found
that this activity, measured with a fluorogenic peptide substrate, increases 3-4fold at 3h-12h of incubation to decline thereafter (Fig. 3c). Interestingly, the
amount of 20S proteasome, as determined by the levels of the constitutive αsubunits, followed the same temporal pattern as that of proteasome activity (Fig
3c, inset). This suggests that oxidative stress causes up-regulation in
proteasome expression most likely to remove the potentially toxic misfolded and
oxidized proteins that build up in cells.

DEM-treatment leads to apoptosis and necrosis of nPC12 cells
We next investigated if partial GSH depletion is toxic to nPC12 cells. As shown
in Fig. 4, the viability of DEM-treated nPC12 cells, as determined by the trypan
blue exclusion test (panel a) and the LDH cytotoxicity assay (panel b), gradually
decreases up to 12 h of incubation and by 24h the proportion of dead cells
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decreases significantly. Similar temporal patterns of cell death were obtained for
detached and adherent cell populations (data not shown), suggesting that dying
cells do not automatically detach from the poly-lysine coated plates. Increased
calpain activity, a marker of both apoptosis and necrosis (Guyton et al., 2005),
was observed between 3-12 h to decline thereafter (Fig. 4c). The increase in
calpain activity is also evident from the reduction in the amount of NFH, one of its
proteolytic targets, (Fig. 4d) and from the retraction of neurites (not shown).
Active caspase-3 expression, a marker of apoptosis (Namura et al., 1998), was
measured by western blotting using an antibody that detects the p17 subunit of
this enzyme but not the full-length 32kDa procaspase-3. As shown in Fig. 4e,
active caspase-3 levels follow an identical temporal pattern as that of the other
two cell-death markers, suggesting that apoptosis accounts for at least a fraction
of the dead cells. Indeed, morphological analysis revealed that approximately
half of the dead cells contain the extensive nuclear fragmentation typical of
apoptotic cells (Fig. 4f). There is, however, an equal amount of cells with swollen
cytoplasm and intracellular vacuoles that are characteristic of necrosis.
Temporal/spatial correlation between protein carbonylation and apoptosis
in GSH depleted nPC12 cells
Since protein carbonylation and cell death shows a similar temporal pattern, we
sought to investigate if there is a spatial relationship between these two
parameters as well. To this end, DEM-treated cells were double stained with
DNPH for protein carbonyls and TUNEL or annexin-V for apoptosis. Consistent
with the results from oxyblot analysis (Fig. 3), the average DNP staining intensity
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per cell reaches a maximum between 3 h and 12 h after addition of DEM to
decline thereafter (Fig. 5a,b). As shown in Fig. 5c, apoptotic (TUNEL positive)
cells stained intensely with DNPH. Since DNPH also stained the nuclei, likely due
to its reactivity towards DNA oligonucleotides (Luo and Wehr, 2009), we
quantified the fluorescence in the cytoplasm. As depicted in panel d, the
fluorescence intensity in the cytoplasm of apoptotic cells was ~ 2 times higher
than that of non-apoptotic cells (Fig. 5d). While there is a significant variation in
DNP staining among the cells, it is clear that the proportion of cells with the
highest cytoplasmic carbonyl content is elevated between 3h and 12h (Fig. 5e).
The temporal/spatial positive relationship between apoptosis and protein
oxidation was further demonstrated by extensive co-localization annexin-V, a late
marker of apoptosis, and DNP immunoreactivity (Fig. 6).
Impaired removal of PCOs increases DEM-induced cell death
To determine if accumulation of oxidized/misfolded proteins plays a role in cell
death, we incubated DEM-treated cells with the proteasome inhibitors
epoxomicin and lactacystin. At a concentration of 1µM, these drugs were found
to reduce the chymotrypsin-like activity of the 20S proteasome by 90.6 ± 13.7%
(lactacystin) and 98.9 ± 7.2% (epoxomicin). Proteasome inhibitors were added to
nPC12 cells 12h after addition of DEM and incubation continued until 24 h. As
depicted in Fig. 7a, cells incubated with the inhibitors have significantly higher
levels of protein carbonyls, indicating that in this system proteasomes are largely
responsible for the degradation of most oxidized proteins. Levels of GSH in the
epoxomicin- and lactacystin-treated cells at 24h of incubation are similar to that
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in untreated cells (Fig. 7b). Under these conditions we found a large increase in
cell death as measured by LDH release (Fig. 7c) and trypan blue exclusion assay
(Fig. 7d). A correlation between protein carbonylation and cell death was also
observed by α-DNP/TUNEL double staining of proteasome inhibited DEM-treated
cells (Fig. 7e). These results further support our hypothesis of a strong
relationship between protein damage and neuronal apoptosis. It is noteworthy
that, in the absence of DEM, epoxomicin and lactacystin do not cause cell death,
suggesting that toxicity of the drug is probably due to its ability to inhibit the
removal of oxidized proteins.
Carbonyl scavengers reduce cell death and protein aggregation in
epoxomicin-treated GSH-depleted cells
The role of protein carbonylation in cell death was further explored using the
classical reactive carbonyl species (RCS) scavengers hydralazine, z-histidine
hydrazide and methoxylamine. These compounds form Schiff bases with the
carbonyl groups and, with the exception of hydralazine, they have no antioxidant
properties (Zheng and Bizzozero, 2010a). In this series of experiments the RCS
scavengers were added together with epoxomicin to cells that had been treated
with DEM for 12h and incubation continued for another 12h. As shown in Fig. 8,
all three drugs reduced protein carbonylation, protein aggregation and cell death,
indicating that (1) protein carbonyls are indeed cytotoxic and (2) protein
aggregation is induced, directly or indirectly, by carbonylation. Preliminary
western blot studies revealed that MDA-, ACR- and 4-HNE-protein adducts are
not formed to any appreciable degree during incubation with DEM, suggesting
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that carbonylation takes place by direct oxidation of amino acid side chain
residues rather than by attachment of reactive carbonyl species to the protein
backbone (data not shown). The effectiveness of the vitamin E analogue trolox at
preventing protein carbonylation and cell dead even when added 12h after DEM
suggests that there is still significant oxidative stress during the recovery phase
(Fig. 8).
Differential effects of cyclosporin A and zVAD-fmk on cell death and
protein carbonylation.
Finally, attempts were made to localize the site of protein oxidation within the
apoptotic pathway. To this end, nPC12 cells were incubated with DEM and either
the MPTP inhibitor cyclosporin A or the pan-capase inhibitor zVAD-fmk. As
shown in Fig. 9, addition of 5µM cyclosporin A prevented all three cell death,
protein carbonylation and protein aggregation induced by GSH depletion. In
contrast, pan-caspase inhibition reduced cell death but has no effect on protein
carbonylation or aggregation (Fig.10). These findings suggest that protein
oxidation/aggregation occurs after MPTP opening but before caspase activation.
3.5 DISCUSSION
In this study we show that a moderate and transient depletion of GSH in nPC12
cells leads to increased accumulation of protein carbonyls and cell death. Both
the amount of PCOs and the proportion of dead cells diminish as GSH is
biosynthetically replenished. However, cell death persists if oxidized proteins are
not removed by the proteasome. These results suggest that the build-up of
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oxidized and/or misfolded proteins is responsible for the loss of cell viability in
this system. Furthermore, the effectiveness of several RCS scavengers at
preventing cell death suggests that protein carbonyls are indeed the toxic
species. Experiments using cyclosporin A and zVAD-fmk place protein
carbonylation downstream of the MPTP opening and upstream of caspase
activation. While the study focused on nPC12 cells, experiments using more
differentiated PC12 cells and primary neuronal cultures yielded the same results,
indicating that the above findings are not circumscribed to partially differentiated
dopaminergic neurons. A schematic model summarizing our experimental
findings is shown in Fig. 11.
DEM is commonly used to deplete both cytoplasmic and mitochondrial GSH and
to cause oxidative stress and cell death (Freeman and Meredith, 1988). At
millimolar concentrations, DEM is highly toxic and causes cell death mostly by
necrosis (Nagai et al., 2002). Our study employed a much lower concentration
(i.e. 50µM) of DEM to achieve the partial GSH depletion detected in the spinal
cord of EAE mice, where there is significant neuronal apoptosis (Dasgupta and
Bizzozero, 2011). Under these conditions, ~50% of the dead cells measured after
12 h of incubation with DEM displayed morphological features that are
characteristic of apoptosis with the rest being necrotic cells. A switch from
apoptosis to necrosis in models with severe oxidative stress has been attributed
to reduction in ATP levels below a threshold level that is insufficient to support
apoptosis, an energy-depended process (Eguchi et al., 1997). The mechanism
linking GSH depletion and increased production of ROS by mitochondria has
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been studied extensively (Armstrong and Jones, 2002; Shen et al., 2005). It is
generally accepted that a decline in the GSH/GSSG ratio leads to the opening of
the MPTP by oxidation of a critical dithiol in the voltage-sensing region of this
protein complex (Petronilli et al., 1994). When GSH falls below a certain level,
permeability transition occurs followed by a collapse in mitochondrial membrane
potential. This event causes enhanced production of superoxide either from the
rise in redox cycling of ubiquinone within complex III (Chen et al., 2003) or from
the reverse electron transport from succinate to NADH within complex I (Lambert
and Brand, 2004). Loss of cytochrome c from mitochondria, after permeability
transition and swelling, can also augment the production of oxygen free radicals
by reducing the redox centers upstream of complex IV (Votyakova and Reynolds,
2005). Our data are in agreement with this model since MPTP inhibition with
cyclosporin A reduces protein oxidation and cell death (both apoptosis and
necrosis). They also indicate that carbonylation occurs after MPTP opening and
as the result of the ensuing high degree of oxidative stress. It should be
emphasized that our findings are not restricted to DEM-induced cell death as a
similar relationship between carbonylation and apoptosis was established in
staurosporine- and BSO-treated nPC12 cells (Supplemental Fig.4 and Fig. 5). It
is also interesting that by 24h of incubation, the surviving cells are able to
replenish the GSH pool completely. Recovery of GSH levels has also been
observed in the brain of rats treated with DEM (Gupta et al., 2000) and in
cultured astrocytes incubated with the DEM-analogue dimethyl fumarate (Lin et
al., 2011), and it is generally ascribed to an antioxidant response that increases
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the amount of γ-glutamylcysteine synthetase, the rate-limiting enzyme of GSH
biosynthesis (Lewerenz and Maher, 2011).
The incorporation of aldehyde and ketone functional groups into proteins takes
place by direct and indirect mechanisms (Bizzozero, 2009). Direct protein
carbonylation involves the metal ion-catalyzed oxidation of Thr, Lys, Arg, and Pro
to α-amino-β-ketobutyric acid, α-aminoadipic semialdehyde and glutamic
semialdehyde, respectively. In contrast, indirect carbonylation entails the reaction
of the nucleophilic centers in Cys, His or Lys residues with RCS, bifunctional
carbonyl-containing molecules derived from the oxidation of lipids (e.g. 4-HNE,
MDA, ACR) and carbohydrates (e.g. glyoxal, methylglyoxal) (Bizzozero, 2009).
Our finding that the RCS scavengers hydralazine, methoxylamine, histidine
hydrazide prevented the formation of protein carbonyls initially suggested that
carbonylation is occurring by an indirect mechanism. However, we were unable
to detect RCS-protein adducts, implying that direct oxidation of amino acids
residues is the most likely process and that the scavengers are able to form
stable adducts with oxidized proteins. It is noteworthy that direct carbonylation
appears to be also the major mechanism underlying the formation of carbonyls in
the CNS of EAE mice (Zheng and Bizzozero, 2010b).
Carbonylated proteins in mitochondria and cytoplasm are digested by the Lon
protease (Bota and Davies, 2002) and the 20S proteasome (Grune et al., 1997),
respectively. While lactacystin is capable of inhibiting both of these proteolytic
systems, epoxomicin is highly specific for the proteasome (Kisselev and
Goldberg, 2001). Thus, our findings suggest that cytoplasmic oxidized proteins
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are likely responsible for damage of nPC12 cells during GSH depletion. The 20S
proteasome by itself plays a critical protective role during oxidative stress by
digesting oxidized proteins via its chymotrypsin-like activity and without
requirement for ubiquitin or energy (Shringarpure et al., 2003). We have
observed a rapid and large rise in proteasome expression and activity upon GSH
depletion. This is in agreement with a recent study showing increased expression
of 20S proteasome, immunoproteasome and the P28α/β regulatory particle upon
incubation of murine embryonic fibroblasts with hydrogen peroxide, which was
interpreted as an oxidative stress adaptation mechanism designed to reduce the
load of oxidized protein in the cell (Pickering et al., 2010). In our system,
however, the elevation in proteasomal chymotrysin-like activity was not sufficient
to prevent the accumulation of PCOs that occurs during first 12h of incubation
with DEM, and addition of epoxomixin or lactacystin results in a further build-up
of oxidized proteins. Interestingly, incubation of nPC12 cells with epoxomicin or
lactacystin alone (i.e. in the absence of DEM) does not lead to any appreciable
increase in protein carbonylation, protein aggregation or cell death, indicating
that basal protein oxidation in these neuron-like cells is quite low. In liver cells,
however, proteasome inhibition causes increased carbonyl formation and protein
aggregation, even in the absence of an obvious oxidative challenge (Demasi and
Davies, 2003). This discrepancy could be attributed to differences in the cell type,
the turnover rate of damaged proteins and the incubation conditions.
It has been shown that carbonylation causes inappropriate inter- and intra-protein
cross-links as well as protein misfolding, which in turn results in the formation of
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high-molecular-weight aggregates (Grune et al., 1997; Mirzaei and Regnier,
2008). As these aggregates get larger they precipitate, become resistant to
proteolytic degradation and reduce cell viability (Nyström, 2005; Maisonneuve et
al., 2008). The precise relationship between protein aggregate formation and
apoptosis, or whether the aggregates are in and of themselves cytotoxic is
unclear. However, it has been recently discovered that protein aggregates, as
they form, sequester multiple preexistent and newly synthesized proteins that
have essential cellular functions and are critical for cell survival (Olzscha et al.,
2011). Our results show that various carbonylation scavengers are able to
prevent protein aggregation and cell death, suggesting that during GSH depletion
oxidized proteins are critical for aggregate formation and cytotoxicity. In our
system, protein aggregates clearly are not made of carbonylated proteins alone
since the cellular amount of carbonylated proteins is roughly 1-2% of that of the
aggregates. However, protein carbonylation may expose hydrophobic surfaces
that can mediate aberrant interactions with other (non-oxidized) proteins,
resulting in their functional impairment and sequestration. Future studies will test
whether agents capable of preventing protein aggregation can also reduce cell
death even in the presence of abundant protein oxidation.
Carbonylation of specific proteins has been found to be toxic as well. For
instance, the occurrence of carbonyls in GAPDH, ANT and Bcl-2 has been
shown to play a role in nitric oxide-induced apoptosis in insulin-producing
RINm5F cells (Cahuana et al., 2004). Carbonyl modification of several
chaperones, including glucose-regulated protein-78, heat-shock protein-60, heat-
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shock protein cognate-71, phosphate disulphide isomerase and calreticulin, has
been linked to apoptosis of irradiated HL60 human leukemia cells (Magi et al.,
2004). Furthermore, apoptosis of etopside-treated HL60 cells is caused by
reduced rate of glycolysis, which likely results from the extensive carbonylation of
several glycolytic enzymes including aldolase, enolase, triose phosphate
isomerase and phosphoglycerate mutase (England et al., 2004). Characterization
of the carbonyl proteome of PC12 cells will determine if similar metabolic
pathways or cellular processes are affected during GSH depletion.
In sum, the present study identifies protein oxidation as an important step in
neuronal cell death triggered by GSH depletion. While it is clear that other
cytotoxic mechanisms may be at play in EAE, it is tempting to speculate that the
reduced levels of GSH and the accumulation of protein carbonyls observed in
this

disease

(Dasgupta

and

Bizzozero,

2011)

play

a

significant

pathophysiological role.
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Fig. 1 - PC12 cells are differentiated into neuron-like cells upon treatment
with NGF. PC12 cells were incubated in the absence or presence of NGF for 24
h as described in Materials and methods section. (a) Representative
immunofluorescence picture of untreated and NGF-treated cells. Nuclear [4′,6diamidino-2-phenylindole (DAPI)] and NFH staining are shown in blue and green
respectively. Note that, 12 h after NGF treatment, cells are no longer round and
flat but show NFH-positive processes that are characteristic of neurons. (b)
Western blots depicting the expression of the neuron-specific markers α-spectrin,
GAP-43 and γ-enolase only in NGF-treated PC12 cells.
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Fig. 2 – DEM induces GSH depletion in nPC12 cells and primary neurons.
(a) Effect of various concentrations of DEM on GSH levels in nPC12 cells at 15
min of incubation. (b–d) Time course of GSH depletion after addition of 50 µM
DEM to PC12 cells differentiated for 1 or 7 days (d) with NGF and to primary
neurons. Values represent the means±S.E.M of 4–9 experiments. Asterisks
denote values that are significantly different from those obtained in untreated
(UT) cells; *P<0.05, **P<0.01, ***P<0.001.
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Fig. 3 – Protein carbonylation and proteasome expression in nPC12 cells
increase upon GSH depletion. (a) Levels of TBARS during the course of DEMinduced GSH depletion. (b) Representative oxyblot of total cell proteins during
the course of DEM-induced GSH depletion (upper panel). Lane intensities were
measured by scanning densitometry and were used to calculate protein carbonyl
levels as described in Materials and Methods (lower panel). (c) Proteasome
chymotrypsin-like activity and proteasome α-subunit expression (inset) in DEMtreated nPC12 cells. Values represent the mean ± SEM of 4 experiments.
Asterisks denote values that are significantly different from those obtained in
untreated (UT) cells; *p<0.05, **p<0.01, ***p<0.001.
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Fig. 4 – Partial GSH depletion leads to apoptosis and necrosis of nPC12
cells. Cells were incubated with 50µM DEM for various periods of time as
described under Materials and Methods. (a) Cell death quantified using the
trypan blue exclusion assay and (b) LDH release. (c) Temporal pattern of calpain
activity, a marker of apoptosis and necrosis. (d) NFH immunostaining intensity.
(e) Levels of active caspase-3 were determined by western blot anaysis (inset).
(f) Quantification of apoptotic and necrotic cell death after 12h of DEM treatment
using morphologic analysis. Values represent the mean ± SEM of 4 experiments.
Asterisks denote values that are significantly different from those obtained in
untreated (UT) cells; *p<0.05, **p<0.01, ***p<0.001.
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Fig. 5 – Temporal and spatial correlation between carbonylation and
apoptosis in DEM-treated nPC12 cells. (a) Immunocytochemical detection of
carbonyls in DEM-treated nPC12 cells at different time points. Carbonyls were
detected with anti-DNP antibodies after derivatization with DNPH (red). TUNEL
staining for apoptosis and 4′,6-diamidino-2-phenylindole (DAPI) staining for
nuclei are shown in green and blue respectively. (b) Total carbonyl content of
DEM-treated nPC12 cells determined by immunocytochemistry. Asterisks denote
values that are significantly different from those obtained in untreated (UT) cells;
*P<0.05, ***P<0.001. (c) Anti-DNP staining in the nucleus and cytoplasm of
TUNEL positive cells. (d) PCO levels in the cytoplasm of TUNEL positive cells
(TPC) and TUNEL negative cells (TNC) at 12 h of treatment with DEM. *P<0.05.
(e) Average fluorescence intensity (Fl) in the cytoplasm of nPC12 cells increases
between 3 and 12 h of incubation with DEM. Values represent the means±S.E.M.
of 100–200 cells per experiment.
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Fig. 6 – Annexin-V positive cells have high carbonyl content. (a) Colocalization of carbonyls and annexin-V in nPC12 cells during GSH depletion.
Carbonyls were detected with anti-DNP antibodies after derivatization with DNPH
(red). Annexin-V staining for apoptosis and DAPI staining for nuclei are shown in
green and blue, respectively. (b) DAPI staining was subtracted from the picture
corresponding to 12h-incubation with DEM to better show the co-localization of
carbonyls and annexin–V. (c) Carbonyl intensity in annexin-V positive cells
(AVPC) and annexin-V negative cells (AVNC) at 12h of treatment with DEM.
Values represent the mean ± SEM of 200 cells per experiment; *p<0.05.
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Fig. 7 - Impaired proteasomal
activity
augments
protein
carbonylation and apoptosis of
DEM-treated nPC12 cells. Cells
were incubated with or without 50µM
DEM for 12h, after which 1µM
epoxomicin (DE12, E12) or 1µM
lactacystin (L12, DL12) was added
to the medium and incubation
continued for another 12h. D24
corresponds to cells incubated with
DEM for the entire 24h-period. (a)
PCO levels determined by oxyblot.
(b) Glutathione assayed by spectrophotometric analysis. (c,d) Cell
death quantified using the trypan
blue exclusion assay and LDH
release. (e) PCO levels in the
cytoplasm of TUNEL positive cells
(TPC) and TUNEL negative cells
(TNC)
in
DEM-treated
cells
incubated for 12h with epoxomixin
(DE12) or lactacystin (DL12). Values
represent the mean ± SEM of 4
experiments.
Asterisks
denote
values that are significantly different
from D24; *p<0.05, **p<0.01,
***p<0.001.
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Fig. 8 – Addition of carbonyl
scavengers to DEM/epoxomicintreated nPC12 cells prevents
protein aggregation and cell
death. Cells were incubated with or
without 50µM DEM for 12h, after
which epoxomocin (1µM) along
with various scavengers (500µM)
were added to the medium and
incubation continued for another
12h. (a) Glutathione levels assayed
by spectrophotometric analysis. (b)
PCO levels determined by oxyblot.
(c) Protein aggregation measured
by differential centrifugation. (d)
Cell death quantified using the
trypan blue exclusion assay.
Values represent the mean ± SEM
of 4 experiments. Asterisks denote
values
that
are
significantly
different (**p<0.01, ***p<0.001)
from untreated cells. Pound
symbols denote values that are
significantly different (#p<0.05,
##
###
p<0.01,
p<0.001)
from
DEM/epoxomicin-treated cells.
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Fig. 9 - Cyclosporin A prevents protein carbonylation, protein aggregation
and cell death (both necrosis and apoptosis) induced by partial GSH
depletion. nPC12 cells were incubated for 12h with 50µM DEM in the absence
or presence of 5µM cyclosporin A (CsA), a classical MPTP inhibitor. (a) The
proportion of necrotic and apoptotic cells determined by morphological analysis
of 400 cells. (b) GSH levels measured by spectrophotometric analysis. (c) PCO
levels measured by oxyblot. (d) Protein aggregation measured by differential
centrifugation. Values represent the mean ± SEM of 3 experiments. Asterisks
denote values that are significantly different (*p<0.05, **p<0.01, ***p<0.001) from
untreated cells. Pound symbols denote values that are significantly different
(#p<0.05, ##p<0.01) from DEM-treated cells.
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Fig. 10 – Pan-caspase inhibition reduces necrosis and apoptosis of nPC12 cells
induced by partial GSH depletion without effecting protein carbonylation or
aggregation. nPC12 cells were incubated for 12h with 50µM DEM in the absence or
presence of 10µM zVAD-fmk, a classical pan-caspase inhibitor (PCI). (a) Representative
oxyblot of total cell proteins. Lane intensities were measured by scanning densitometry
and were used to calculate PCO levels (b). (c) Western blot of total cell proteins
developed with anti-caspase-3 antibody. (d) GSH levels measured by
spectrophotometric analysis. (e) The proportion of necrotic and apoptotic cells
determined by morphological analysis of 400 cells. (f) Protein aggregation measured by
differential centrifugation. Values represent the mean ± SEM of 5 experiments. Asterisks
denote values that are significantly different (*p<0.05, **p<0.01, ***p<0.001) from
untreated cells. Pound symbols denote values that are significantly different (#p<0.05,
##
p<0.01) from DEM-treated cells.
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Fig. 11 – Schematic diagram that incorporates the major findings of this
study. Partial GSH depletion increases the production of mitochondrial
ROS, which are responsible for the incorporation of carbonyl groups into
proteins. The rise in proteasomal expression and activity that occurs during the
first 12h of incubation is not sufficient to overcome the increase in protein
oxidation (indicated as ↑[O]/PA or increased oxidation/protasome activity ratio),
leading to the progressive accumulation of PCOs. Some cells accumulate more
PCOs than others perhaps reflecting variations in antioxidant defense
mechanisms and/or in proteasome expression. When protein oxidation reaches a
threshold value (3h-12h of incubation), it triggers apoptosis/necrosis. As
incubation progresses, dead cells are removed from the system and the surviving
cells slowly replenish their GSH to normal levels, leading to a ↓[O]/PA ratio, a
decline in PCO accumulation and reduced cell death. Addition of epoxomicin
(EPO) at the beginning of this period prevents the proteasome-mediated removal
of damaged proteins causing a build-up of PCOs and loss of cell viability. These
effects are prevented by several RCS scavengers, indicating that protein
carbonylation is indeed toxic to cells.
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Fig. 1 (supplementary): Methacarn and paraformaldehyde fixatives had similar effect
on DNP staining of carbonyls in nPC12 cells. (a) Immunocytochemical detection of
carbonyls with anti-DNP after derivatization with DNPH (red) using different fixatives. (b)
Quantitative representation of carbonyl levels using different fixatives on nPC12 cells
incubated with 50µM DEM for 12h. Values represent the mean ± SEM of 3 experiments.
Asterisks denote values that are significantly different (***p<0.001) from untreated cells (UT).
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Fig. 2 (supplementary): Incubation with HCl did not affect TUNEL staining in
nPC12 cells. (A) Immunocytochemical detection of TUNEL positive cells
(green) under different conditions. (B) No changes in the number of TUNEL
positive cells upon incubation with DNPH or HCl or both. (C) Increase in TUNEL
positive cells to similar extent as compared to its respective untreated controls
using different fixatives on nPC12 cells incubated with 50µM DEM for 12h. Values
represent the mean ± SEM of 3 experiments. Asterisks denote values that are
significantly different (***p<0.001) from untreated cells (UT).
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Fig. 3 (supplementary): Damaged-nuclei stains with anti-DNP in nPC12 cells. (A)
Immunocytochemical detection of carbonyls with anti-DNP after derivatization with DNPH
(red) and TUNEL positive cells (green) under different conditions using paraformaldehyde
as a fixative. Majority of nuclei of nPC12 cells incubated with DNase I stained positive for
TUNEL and carbonyls. Increase in the number of TUNEL positive cells (TPC) was observed
in nPC12 cells incubated either with 5µM of STS for 16 hours or 50µM DEM for 12h. (B)
Quantitative representation of carbonyl intensity in the cells, nucleus and cytoplasm of TPC
as compared to the TUNEL negative cells (TNC) when incubated with 5µM of STS for 16
hours or (C) with 50µM DEM for 12h. Values represent the mean ± SEM of 3 experiments.
Asterisks denote values that are significantly different (*p<0.05, **p<0.01, ***p<0.001) from
untreated cells (UT).
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Fig. 4 (supplementary) - Positive relationship between carbonylation
andapoptosis in staurosporin-treated nPC12 cells. Cells were incubated with
5µMstaurosporin (STS) for 3h. (a) Immunocytochemical detection with antiDNPantibodies after derivatization with DNPH (red). TUNEL staining for
apoptosis and DAPI staining for nuclei are shown in green and blue, respectively.
(b) GSH levels determined by spectrophotometry. (c) Proportion of apoptotic cell
determined by TUNEL. (d) Total carbonyl content determined by
immunocytochemistry. (e) PCO levels in the cytoplasm of TUNEL positive cells
(TPC) and TUNEL negative cells (TNC) at 3h of treatment with staurosporin.
Values represent the mean ± SEM of 3 experiments. **p<0.01, ***p<0.001.
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Fig. 5 (supplementary) – BSO-induced GSH depletion also increases
carbonylation and cell death. (a) GSH levels in nPC12 cells incubated with
200µM BSO for different time periods. (b) PCO levels in nPC12 cells incubated
with 200µM BSO for 3h. (c) Cell death quantified using the LDH release and
trypan blue exclusion assay (d) following 3h-incubation with 200µM BSO. Values
represent the mean ± SEM of 3 experiments. Asterisks denote values that are
significantly different (*p<0.05, ***p<0.001) from untreated cells (UT).
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4.1 Abstract
A major consequence of protein carbonylation is the formation of high-molecular
weight protein aggregates, which are believed to be cytotoxic. We have
previously shown that incubation of neuron-like PC12 cells with 50µM DEM
(diethyl maleate) leads to partial depletion of glutathione (GSH) and the ensuing
increase in protein carbonyls, protein aggregates and cell death (both by
necrosis and apoptosis). In the present study we used the same in vitro model of
oxidative stress and various carbonyls scavengers and protein aggregation
inhibitors in an attempt to strengthen the relationship between protein oxidation,
aggregation and apoptosis. The results show that the carbonyl scavengers
hydralazine and aminoguanidine (both at 500µM) prevent protein carbonylation,
aggregation and cell death caused by GSH depletion. Furthermore, inhibition of
protein aggregation with 10µM congo red (CR) or 5µM 2-hydroxypropyl βcyclodextrin (HPCD) significantly reduced neuronal cell death without affecting
the levels of oxidized proteins. Interestingly, we failed to observe the presence of
large, juxta-nuclear aggregates (aggresomes) upon GSH depletion, suggesting
that the small protein aggregates are the cytotoxic species. Together, these data
support our hypothesis that, during severe oxidative stress, carbonylation triggers
the formation of small-size protein aggregates to cause neuronal apoptosis
Running Title: Protein aggregation inhibitors prevent neuronal cell death
Key Words: Apoptosis, carbonylation, cell death, glutathione depletion, protein
aggregation.

94

4.2 INTRODUCTION
Many CNS disorders are characterized by oxidative stress induced by
overproduction of reactive oxygen species (ROS) and/or failure of the antioxidant
defense system. High levels of ROS result in the irreversible, deleterious effects
on many cellular components and processes, which trigger cell death (Klein and
Ackerman, 2003; Leonardi and Mytilineou, 1998). A major outcome of severe
oxidative stress is the formation of protein carbonyls. Increased build-up of
oxidized proteins causes substantial alterations in cellular functions that are
predominantly cytotoxic (Magi et al., 2004; Curtis et al., 2012; Norberg et al.,
2010; Dasgupta et al., 2012). Augmented protein carbonylation and neuronal
apoptosis are major features of chronic neurological disorders, including
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and multiple
sclerosis (MS) (Bizzozero, 2009).
A rise in the amount of carbonylated proteins is often associated with the
formation of protein aggregates (Erjavec et al., 2007; Squier, 2001; Grune et al.,
2005). Carbonylation is thought to promote protein aggregation by causing
misfolding and exposing hydrophobic regions, which triggers hydrophobic
interactions between polypeptides and the formation of supra-molecular
assemblies of multiple proteins (Grune et al., 1997). Despite the cytotoxic role of
protein aggregates in neurodegeneration is a well established phenomenon
(Ross and Poirier, 2004; Lansbury and Lashuel, 2006), the molecular
mechanisms for aggregation-associated proteotoxicity is not well understood.
Protein aggregates, once formed, can disrupt cellular functions and serve as
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nucleation sites for the aggregation of other unrelated proteins, in a manner that
further enhances the fraction of misfolded proteins in the cell (Lamark and
Johansen, 2012; Wickner et al., 1999; Bosshard et al., 2010). It is likely that
compartmentalization within the aggregate of proteins that are vital for cell
survival leads to cytotoxic responses (Trzesniewska et al., 2004; Hachiya et al.,
2008; Ross and Poirier, 2004; Olzcha et al., 2011). However, it has been argued
aggregates may also elicit cytoprotective responses by sequestration of toxic
proteins (Dobson, 2003, Zhu et al., 2000).
Recent immunohistochemical studies in the spinal cord of mice with experimental
autoimmune encephalomyelitis (EAE), a widely used animal model of MS,
revealed that protein carbonylation and protein aggregation have a positive
temporal correlation with neuronal/oligodendrocyte apoptosis (Chapter 2). Using
a cell culture model of oxidative stress consisting of glutathione-depleted
neurons, we recently found that both protein carbonylation and protein
aggregation precede apoptosis (Dasgupta et al., 2012; Chapter 3). Moreover,
several carbonyl scavengers not only prevented cell death but also reduced the
amount of protein aggregates. Yet, the above investigations did not prove
conclusively that protein aggregation has a critical role in cell death. The present
study was designed to fill this gap by testing the effect of the protein aggregation
inhibitors congo red (CR) and 2-hydroxypropyl-β-cyclodextrin (HPCD) on
neuronal cell death induced by partial GSH depletion. The results clearly show
that both agents not only prevent the formation of protein aggregates but also
inhibit cell death without affecting the levels of protein carbonylation. Moreover,
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we failed to observe the presence of large, juxta-nuclear aggregates
(aggresomes) upon GSH depletion, suggesting that the small protein aggregates
are the cytotoxic species.
4.3 MATERIALS AND METHODS
Neuronal cultures and drug treatments
Rat adrenal medullary pheochromocytoma (PC12) cells were cultured on poly-Llysine-coated 6-well plates (BioCoat™, BD Biosciences, Bedford, MA) in RPMI1640 media containing 10% serum (7.5% donor horse and 2.5% fetal calf serum;
Sigma, St. Louis, MO) and an antibiotic/antimycotic mixture (Invitrogen Corp.,
Carlsbad, CA). Cells grown at 60-70% confluence were differentiated into a
neuronal phenotype by incubation with 100 ng/ml of nerve growth factor (NGF;
Sigma) for 24h as described by Harms et al. (2010). Cells were incubated for 12
h with the GSH depletor diethylmaleate (DEM, Sigma) in the absence or
presence of congo red (Enzo Life Sciences, Plymouth Meeting, PA), 2hydroxypropyl β-cyclodextrin (Sigma), hydralazine (Sigma), or aminoguanidine
(Sigma). Control cells were left untreated after incubation with NGF.

After

incubation, cells were homogenized in PEN buffer (20 mM sodium phosphate,
pH 7.5, 1 mM EDTA, and 0.1 mM neocuproine) containing 1 mM dithiothreitol.
For GSH determination, cells were homogenized in PEN buffer without reducing
agents and were processed immediately as described below. Protein
homogenates were stored at -80°C until use. Protein concentration was
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assessed with the Bio-Rad DC™ protein assay (Bio-Rad Laboratories; Hercules,
CA) using bovine serum albumin as standard.
Determination of GSH
GSH levels were determined by enzymatic recycling method (Shaik and Mehvar,
2006). Briefly, proteins from cell homogenates were precipitated with 1%
sulfosalicylic acid and removed by centrifugation at 10,000g for 15min. Aliquots
of the supernatant were then incubated with 0.4U/ml glutathione reductase,
0.2mM NADPH, and 0.2mM 5,5’-dithiobis-(2-nitrobenzoic acid) in 1ml of 0.2M
sodium phosphate buffer pH 7.5 containing 5mM EDTA. The rate of appearance
of the thionitrobenzoate anion was measured spectrophotometrically at 412 nm.
[GSH] was calculated by interpolation on a curve made with increasing
concentrations of GSSG (0.1-10nmol).
Oxyblot analysis
Protein carbonyl groups were measured by oxyblot analysis as described earlier
(Smerjac and Bizzozero, 2008). In brief, proteins (5µg) were incubated with 2,4dinitrophenylhydrazine

to

form

the

2,4-dinitrophenyl

(DNP)

hydrazone

derivatives. Proteins were separated by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis on 10% gels and blotted to polyvinylidene difluoride
membranes. DNP-containing proteins were detected using rabbit anti-DNP
antiserum (1:500) and horseradish peroxidase-conjugated goat anti-rabbit IgG
antibody (1:2,000). Blots were developed by enhanced chemiluminescence using
the Western Lightning ECL™ kit from Perkin-Elmer (Boston, MA). Developed
98

films were scanned in a Hewlett Packard Scanjet 4890 and the images were
quantified using the NIH Image 1.63 imaging analysis program. The intensity of
each lane on the film was normalized by the amount of coomassie blue staining
in the corresponding lane.
Cell viability assays
Cell death was determined by measuring lactate dehydrogenase (LDH) activity
on a 10µl-aliquot from the cell supernatant using the LDH-cytotoxicity assay kit II
(ABCAM, Cambridge, MA).
Protein aggregation assay
Cell homogenates prepared in PEN buffer containing 1mM dithiothreitol and
150mM NaCl were centrifuged at 20,000xg for 30 min at 4°C. The pellets were
then extracted with the same buffer containing 1% triton X-100. Samples were
kept on ice for 15 min and were centrifuged at 20,000xg for 30 min at 4°C. The
final pellet, which contains some cytoskeleton structures but mostly aggregated
proteins, was re-suspended in PEN buffer for protein determination. In some
cases, samples were analyzed by SDS-PAGE as described above.
Cytochemical detection of aggresomes
Cells, cultured on 12 mm round poly-lysine coated coverslips (BD BioCoat™)
were fixed with 4% paraformaldehyde for 20 min. Fixed cells were then incubated
for 30 min with ProteoStat® Protein Aggregation Assay solution (Enzo Life
Sciences). Cellular nuclei were stained with DAPI (40ng/ml, Sigma). Stained
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sections were mounted using 1,4-diazabicyclo[2.2.2]octane in polyvinyl alcohol
(Sigma) as antifading agent.
Statistical analysis
Results were analyzed for statistical significance with student t-test using
GraphPad Prism® program (GraphPad Software incorporation, San Diego, CA).
4.4 RESULTS
Strong correlation between protein carbonylation, aggregation and
neuronal cell death. PC12 cell cultures have been widely used as model system
for studying apoptosis in neurodegenerative diseases (Kruttgen et al., 1998;
Rukenstein et al., 1991; Cheung et al., 2000). These cells differentiate into
dopaminergic neurons when treated with low concentrations of nerve growth
factor (Das et al., 2004; Meakin and Shooter, 1992; Dasgupta et al., 2012). As in
our previous work (Dasgupta et al., 2012), we used diethyl maleate (DEM) to
reduce intracellular GSH levels. This electrophilic reagent rapidly conjugates to
GSH by a reaction catalyzed by glutathione-S-transferase (Buchmüller-Rouiller et
al., 1995), making the tri-peptide unavailable for the reduction of many oxidized
metabolites. This leads to mitochondrial production of reactive oxygen species
and the development of oxidative stress (Bizzozero et al., 2006). After 12h of
incubation with DEM, there is a 30% reduction in GSH levels, followed by GSH
replenishment at 24h (Fig. 1a). Concomitant with GSH depletion observed after
treatment with DEM for 12h, there is a 50% increase in the amount of protein
carbonyls and 300% rise in the amount of aggregated protein, both of which
100

return back to control values by 24h of incubation (Fig.1b, c). In all experimental
conditions approximately one-half of the carbonylated proteins are present in the
detergent-insoluble pellets, suggesting that protein carbonyls are integral part of
the protein aggregates (Figure 1d). Concurrent with the accumulation of
carbonylated proteins and protein aggregates, the extent of cell death, assessed
by LDH release into the incubation medium, is also high at 12h of incubation with
DEM to decrease thereafter (Fig. 1e). Furthermore, using data points
corresponding to incubation periods shorter than 12h, we found that the amount
of protein aggregates display a high correlation with both protein carbonylation
(Fig. 2a) and cell death (Fig. 2b). These data strongly suggest a possible
association between protein carbonylation and protein aggregation in mediating
cell death.
Carbonyl scavengers prevent protein aggregation and cell death. As
depicted in Fig. 3, the carbonyl scavengers aminoguanidine and hydralazine
reduced the amount of carbonylated proteins formed upon GSH depletion for 12h
(Fig 3). Furthermore, these agents also prevented the formation of protein
aggregates and cell death as compared to the samples incubated with DEM
alone. Similar results were found in our previous study using histidine hydrazide
and methoxylamine as carbonyls scavengers (Dasgupta et al., 2012; Chapter 3).
These data clearly suggest that protein carbonylation causes protein aggregation
and neuronal cell death in this in vitro system.
Inhibition of protein aggregation prevents cell death without affecting
protein oxidation. We next investigated whether protein aggregation plays a
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critical role in neuronal cell death induced by GSH depletion. Towards this end,
we selected CR and HPCD. Both of these drugs are known protein aggregate
inhibitors at low concentrations and do not display any antioxidant properties. As
shown in Fig. 4, 5µM HPCD and 10µM of CR inhibited protein aggregation and
prevented DEM-induced cell death, without affecting the levels of protein
carbonylation. These results demonstrate an ordered mechanistic pathway for
mediating neuronal cell death under severe oxidative stress, where carbonylation
leads to the formation of protein aggregates to mediate neuronal cell death (Fig.
5).
Large protein aggregates (aggresomes) do not form during GSH depletion.
Cytochemical experiments were conducted to determine if DEM-induced
neuronal cell death is related to the formation of large juxta-nuclear aggregates
(a.k.a. aggresomes). This is important since the protein aggregation assay used
until this point measures both small and large aggregates. Aggresomes were
detected using the ProteoStat® protein aggregation dye. Surprisingly, the
number of large protein aggregates in DEM-treated neurons, even in the
presence of the proteasome inhibitor epoxomycin, was very small and
indistinguishable from that of control cells (Fig. 6). A positive control made of
nPC12 cells treated with the non-specific proteasome inhibitor MG132 led to the
formation of aggresomes in most cells, thereby validating this technique for the
detection of large protein aggregates. These results suggest that small protein
aggregates rather than aggresomes are the inducer of cytotoxicity during partial
depletion of GSH.
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4.5 DISCUSSION
Accumulation of aggregated proteins is normally considered a cytotoxic process
(Estus et al., 1997; Zhu et al., 2000) and has long been associated with
neurodegeneration (Lansbury and Lashuel, 2006). The results from the present
work are generally in agreement with this notion. Using an in vitro model of
oxidative stress that mimics the reduction in GSH levels observed in
inflammatory demyelinating disorders such as EAE (Chapter 2) and MS
(Bizzozero et al., 2005), we showed that (1) there is a positive temporal
correlation between protein oxidation, aggregation and neuronal death, (2)
carbonyl scavengers prevent both protein aggregation and cytotoxicity, (3)
inhibition of protein aggregation significantly reduces cell death without affecting
the levels of oxidized proteins, and (4) protein aggregates of large size do not
form to any appreciable extent. Together, these data support the hypothesis that
carbonylation triggers the formation of small-size protein aggregates to cause
neuronal apoptosis (Fig. 5).
Our findings also suggest that, at least in this in vitro system, carbonylated
proteins are not harmful by themselves but mediate their toxic effects by inducing
protein aggregation. Although the mechanism(s) underlying the assembly of
protein aggregates during oxidative stress is presently unknown, we have found
that carbonylated proteins are not only enriched in the aggregates but also are
critical for aggregate formation. It is noteworthy, however, that just a small
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fraction (1-2%) of the proteins present in the aggregates are modified by
carbonylation. Yet, the incorporation of carbonyl groups (and the ensuing
elimination of positive charges) on specific amino acid residues may cause
misfolding, thereby exposing hydrophobic surfaces that can mediate aberrant
interactions with other (non-oxidized) proteins, as was recently proposed for
several cerebral proteopathies (Walker and LeVine, 2012). It is likely that as
these abnormal complexes form and grow in size, they may sequester many
proteins that are vital for cell survival leading to neurotoxicity and cell death
(Trzesniewska et al., 2004; Hachiya et al., 2008; Ross and Poirier, 2004; Olzcha
et al., 2011).
In chapter 2, I showed that concomitant with increased levels of carbonylated
proteins in the spinal cord of EAE mice there is a rise in the amount of cells
containing large juxta-nuclear protein aggregates. Thus, it was surprising to
discover that GSH-depleted PC12 cells do not contain aggresomes or any other
aggregates that are large enough to be detected with the ProteoStat® dye.
Moreover, large aggregates were not detected even when DEM-treated cell were
incubated in the presence of the proteasome inhibitor epoxomycin (Fig. 6), a
condition that further increases cell death, the levels of protein carbonyls and the
amount of protein aggregates determined with a biochemical technique
(Dasgupta et al., 2012). Based on these findings, it is fair to conclude that smallsize protein aggregates are actually neurotoxic. Indeed, a number of recent
studies have suggested that aggresomes, in contrast to small protein
aggregates, are cytoprotective (Kopito, 2000; Zhang and Qian, 2011; Lamark

104

and Johansen, 2012). It is noteworthy that incubation of nPC12 cells with the
proteasome inhibitor MG132 leads to the formation of aggresomes in most cells.
However, this is likely due to the fact that MG132, in contrast to epoxomycin, is
not a very specific and can also inhibit the lysosomal-cathepsins (Kadlčíková et
al., 2004), thereby interfering with the autophagy process and the removal of
larger aggregates. This suggests that the decreased autophagy index, rather
than augmented carbonylation, is perhaps the major factor triggering the
formation of aggresomes in acute and chronic EAE (Chapter 2).
We have shown for the first time that CR and HPCD inhibit carbonylationtriggered protein aggregation and the ensuing neuronal cell death. Their
inhibitory activities can be attributed to their hydrophobicity, which possibly
functions to prevent the assembly of aggregated proteins or to facilitate their
disassembly. CR is known to interfere with polypeptide misfolding and to stabilize
native protein monomers or partially misfolded intermediates (Podlisny et al.,
1995) whereas HPCD has a detergent-like activity that can help in the refolding
process, thereby preventing the protein association (Wang, 2005). Yet,
regardless of their mechanism of action, agents like CR and HPCD may become
in the future important tools to evaluate the causative and consequential role of
protein aggregation in the pathogenesis and progression of EAE. Indeed, CR has
already been shown to have an ameliorative effect in cell and animal models of
other neurological disorders, including Alzheimer’s, Parkinson’s, Huntington’s
and prion diseases (Frid et al., 2007).
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Fig. 1 – Time-course changes in
protein carbonylation, protein
aggregation and cell death in
DEM-treated nPC12 cells. (a)
Effect of 50µM DEM on GSH
levels, (b) Levels of protein
carbonyls measured by oxyblot
analysis, (c) Protein aggregates
determined by calculating the
protein concentration in the triton
insoluble pellets, (d) percentage
of protein carbonyls partitioning
into the protein aggregates, and
(e) cell death assayed by LDH
release at 12h and 24h of
incubation with DEM. Values
represent the mean ± SEM of 4
experiments. Asterisks denote
values that are significantly
different from those obtained in
untreated (UT) cells; *p<0.05,
**p<0.01, ***p<0.001.
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Fig. 2 – Positive correlation exists between protein carbonylation, protein
aggregation and cell death. Correlation curves showing strong positive
correlation (a) between protein aggregation and protein carbonylation (r=0.97)
and (b) between cell death and protein aggregation (r=0.98) in GSH-depleted
nPC12 cultures. Each point represents the average values from 3 experiments.
Asterisks denote the significance of Pearson correlation coefficient (r); *p<0.05,
**p<0.01.
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Fig. 3 – Carbonyl scavengers
prevent protein aggregation and
cell death in DEM-treated nPC12
cells. Cells were incubated with
50µM DEM for 12h along with
either 500µM of aminoguanidine
(AG) or hydralazine (HZ) (a)
[GSH]
was
measured
by
spectrophoto-metric analysis. (b)
Protein
carbonyls
were
measured by oxyblot analysis.
(c) Protein aggregation was
assayed
by
differential
centrifugation. (d) Cell death was
quantified using LDH release.
Values represent the mean ±
SEM of 4 experiments. Asterisks
denote
values
that
are
significantly different (**p<0.01,
***p<0.001) from untreated cells
(UT). Pound symbols denote
values that are significantly
different (#p<0.05, ##p<0.01,
###
p<0.001) from DEM-treated
cells.
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Fig. 4 – Inhibition of protein aggregation blocks DEM-induced nPC12 cell death
without affecting protein oxidation. Cells were incubated with or without 50µM
DEM along with either 10µM of congo red (CR) or 2-hydroxypropyl β-cyclodextrin
(HPCD) for 12h. (a) Protein aggregation levels were measured by differential
centrifugation. (b) Cell death was determined by LDH release (c) Protein
carbonyl levels were quantified by oxyblot analysis. Values represent the mean ±
SEM of 3 experiments. Asterisks denote values that are significantly different
(**p<0.01, ***p<0.001) from untreated cells (UT). Pound symbols denote values
that are significantly different (#p<0.05, ##p<0.01, ###p<0.001) from DEM-treated
cells.
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Fig. 5 – Schematic diagram representing the key findings of this study. Partial
GSH depletion increases ROS levels in the nPC12 cells. Excessive ROS leads to
the progressive accumulation of carbonylated proteins, which causes protein
misfolding and triggers the formation of small-size protein aggregates. These
cytotoxic aggregates ultimately cause neuronal death by apoptosis or necrosis.
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Fig. 6 – Partial GSH depletion does not induce additional large-size protein
aggregates (aggresomes) in nPC12 cells. Cells were incubated with MG132,
50µM DEM or 50µM DEM + epoxomycin (EPO) for 12h. Protein aggregation was
detected with the Proteostat® detection kit. UT, untreated cells.
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5. Discussion
5.1 Oxidative stress and cell death
Acute oxidative stress may result in cell death via apoptosis or necrosis (England
and Cotter, 2004). Due to the critical role of cell death in the pathophysiology of
inflammatory demyelination, the identification of the processes responsible for
apoptosis/necrosis have become the subject of intense study. Proteases like
calpain and caspases play a central role in cell death. Elevation of calpain
(marker of apoptosis and necrosis) and caspases (marker of apoptosis) in EAE
and neuronal cells in culture (this study) indicates that both apoptosis and
necrosis may take place simultaneously. Further, inhibition of calpain prevents
cell death in EAE rats (Das et al., 2008). Since increased calpain activity is also
found in the CNS of MS patients (Imam, 2007), it is possible that calpainregulated mechanism of cell death, with both apoptosis and necrosis, might be
happening at the same time in the CNS of these patients.
Multiple mechanisms have been proposed to explain how oxidative stress
triggers cell death. One of these processes involves reduced glucose utilization
during oxidative stress. It is believed that protein oxidation can inhibit glycolytic
enzymes resulting in reduced glucose utilization and ATP production (England et
al., 2004). When ATP levels reach a lower threshold, cells switch from apoptosis
to necrosis because apoptosis is an energy dependent process (England et al.,
2004; Troyano et al., 2001). The ultimate fate of a dead cell regardless of the
type of cell death is its removal via phagocytosis (Krysko et al., 2006). Necrotic
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cells are notorious for the release of their intracellular contents, which may elicit
the production of inflammatory cytokines and the activation of immune system
(Iyer et al., 2009). Both of these processes have a detrimental effect on
neighboring cells further promoting tissue injury. It is generally accepted that
apoptosis, in contrast to necrosis, does not lead to an inflammatory response.
Yet, when there is massive apoptosis such that phagocytic activity is not
sufficient to remove the dying cells, inflammation, oxidative stress and
subsequent increase in cell death become apparent leading to a vicious
detrimental cycle (Denecker et al., 2001).
Autophagic cell death under oxidative stress conditions is an important
mechanism for elimination of cancer cells (Chen and Kilonsky, 2011), while in
normal cells autophagy is mostly cytoprotective. For example nutrient deprivation
(including glucose, lipids and amino acids) and starvation (Chen and Kilonsky,
2011) induces autophagy (Levine and Yuan, 2005) to recycle intracellular
cytoplasmic components. This, in turn, supports mitochondrial energy production
needed for cell survival (Levine and Yuan, 2005). Excessive autophagy,
however, may be lethal as most of the cytoplasm is consumed due to its
excessive digestion (Zhao et al., 2008). Yet, direct cell death by autophagy is
relatively uncommon and applicable only under specific scenarios (Denton et al.,
2011).
Oxidative damage-associated mitochondrial dysfunction results in energy
depletion and cell death (Ryter et al., 2007). Recently, mitochondrial dysfunction
with subsequent energy failure has been postulated to contribute to MS
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pathogenesis (Witte et al., 2009) by promoting neurodegeneration during the
onset and progression of the disease (Lee et al., 2012). Moreover, low levels of
ATP and high levels of ATP-derived metabolites are found in the cerebro spinal
fluid of MS patients (Tavazzi et al., 2011). Thus, the demise of CNS cells in MS
patients may be partly due to oxidative stress and ATP depletion that take place
in both neurons and glial cells (Figure 1). Oxidative stress is a major inducer of
neuronal cell death (Schmuck et al., 2002; Watts et al., 2005, Harrison et al.,
2005) and my observation of a 30% decrease in the number of neurons in the
spinal cord of mice with acute EAE concomitant with the decrease in GSH levels
strongly suggest that oxidative stress is an important cytotoxic mechanism.

Figure 1: Cellular communication has additive impact of oxidative stress. Normally
astrocytes protect neurons from oxidative stress by releasing glutathione (GSH) for its
direct uptake by neurons. However, when astrocytes are activated they start generating
ROS along with other cells (activated macrophages, damaged neurons, oligodendrocytes
etc), accumulate and release ROS in excess that result in the ultimate demise of neurons
and oligodendrocytes.
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5.2 Differential cellular response to oxidative stress and accumulation of
protein carbonyls
Severe oxidative stress can modify proteins leading to neuronal damage
(Bharath and Anderson, 2005). One of the major protein modifications during
oxidative stress is the formation of protein carbonyls. Inflammatory disorders
such as MS and EAE are often associated with sustained periods of severe
oxidative stress resulting in the accumulation of oxidized proteins (Smerjac and
Bizzozero, 2008; Zheng and Bizzozero, 2010). However, my study revealed that
carbonylated proteins accumulate in acute EAE (where oxidative stress is high)
as well as in chronic EAE (where GSH and TBARS levels are normal). The latter
is due to decreased proteasomal activity in chronic EAE.

Thus, apoptosis

correlates better with the build-up of protein carbonyls that with oxidative stress.
Due to a number of reasons described in the introduction to this dissertation,
CNS cells are more susceptible to oxidative damage than those from other
tissues. Additionally, different CNS cells have unique responses to oxidative
stress and display variable build-up of protein carbonyls. In fact, I have observed
that different CNS cell types (astrocytes, oligodendrocytes and neurons) vary in
their sensitivity to oxidative stress and that nPC12 cells accumulate different
levels of protein carbonyls when subjected to similar oxidative stress conditions.
As shown in Chapter 2, astrocytes contain the highest levels of carbonyls in both
control and EAE spinal cord, followed by oligodendrocytes and neurons. This is
perhaps due to the large amounts of ROS produced by astrocytes and microglial
cells (Keller et al., 1999), which could oxidize endogenous proteins. Yet, it was
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somewhat surprising to discover that the basal carbonyl staining in neurons and
oligodendrocytes are significantly lower, particularly when these two cell types
are considered to be highly susceptible to oxidative damage (Halliwell, 2006;
Benarroch, 2009). Interestingly, the notion that astrocytes are less sensitive to
oxidative damage than other CNS cells has been recently challenged, as they
were found to contain significantly lower GSH levels in vivo than neurons and
oligodendrocytes (Miller et al., 2009). Another possibility is that oligodendrocytes
and neurons may have a more efficient proteolytic machinery to remove oxidized
proteins thus reducing the build up of carbonylated proteins in these cells.
5.3 Carbonylated proteins are cytotoxic
My data also suggest that shortly after the cells reach a threshold level of protein
carbonyls, the plasma membrane becomes leaky (as evident from LDH release
in DEM-treated nPC12 cells) and the cells rapidly die either by necrosis or
apoptosis. Most likely, cells initially marked for apoptosis switched to necrosis as
ATP became limiting. It is noteworthy that the subpopulation of glutathione
depleted nPC12 cells that selectively accumulated the highest amount of protein
carbonyls was also TUNEL positive. I also detected an equal number (~10-11%)
of apoptotic and necrotic cells. Further, scavenging protein carbonyls prevented
both type of cell death. Increased carbonylation of TUNEL positive cells was also
observed in the spinal cord of EAE mice. These data suggest a critical role of
protein carbonylation in both nPC12 cell death and in inflammatory demyelinating
disorders. In the future, it will be important to develop and test specific carbonyl
scavengers to determine whether or not this oxidative protein modification
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significantly contributes to the pathophysiology of EAE. This approach is not
without challenges since many carbonyl scavengers have anti-inflammatory
properties, and inactivation of the immune system will undoubtedly ameliorate
EAE. Thus, these drugs will have to be administered later in the disease course
where inflammation in minimal.

Figure 2: Possible mechanisms suggested for induction of apoptosis by protein
carbonyls. Apoptosis inducing factor (AIF), adenine nucleotide protein (ANT) and B-cell
lymphoma 2 (Bcl-2) are mitochondrial membrane proteins. Carbonylation of AIF has been
shown to signal for apoptosis. ANT carbonylation precedes opening of MPTP that causes
apoptosis. Degradation of anti-apoptotic protein, Bcl-2 occurs subsequent to its carbonylation
followed by cellular apoptosis. Carbonylation of glycolytic protein glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) takes place before its nuclear translocation for apoptotic signaling.

There is evidence suggesting that after incorporation of carbonyl groups into
specific proteins there are alterations in signaling leading to apoptosis (Cahuana
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et al., 2004; Norberg et al., 2010). For example, carbonylation of B-cell
lymphoma-2

(Bcl-2,

anti-apoptotic

protein)

precedes

its

downregulation

(Cahuana et al., 2004) and decreased Bcl-2 levels is a feature that happens prior
to apoptosis (Xie et al., 1997; Krisch et al., 1999). Bcl-2 and antioxidants can
prevent adenine nucleotide protein (ANT) dependent opening mitochondrial
permeability transitional pore (MPTP) (Vieira et al., 2001), a critical for apoptosis
(Kroemer et al, 2007; Dasgupta et al., 2012). ANT, a component of MPTP, is
carbonylated during oxidative stress (Giron-Calle et al., 1994; Cahuana et al,
2004) but is unclear if this causes MPTP-mediated apoptosis. Another example
is the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
which when carbonylated not only decreases its specific activity (Gomez-Pator et
al., 2012) but also increases its translocation from cytoplasm to nucleus
(Cahuana et al., 2004). However, while nuclear translocation of GAPDH is known
to induce apoptosis (Tajima et al., 1999) direct evidence linking the specific
carbonylation of GAPDH to apoptosis is still lacking. The only molecular event
that documents apoptotic signaling by a carbonylated protein is through
apoptosis inducing factor (AIF). AIF is a mitochondrial protein, whose
susceptibility to calpain-mediated cleavage augments significantly after its
carbonylation. Cleaved AIF migrates to the nucleus to induce apoptosis (Norberg
et al., 2010). All of these molecular mechanisms have been integrated to show
the possible induction of apoptosis via carbonylation of specific proteins (Figure
2). This picture, however, does not include another major consequence of protein
oxidation, namely the formation of toxic protein aggregates.
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Figure 3: Most carbonylated and poly-ubiquitinated proteins in MS partition into the
fraction containing aggregated proteins. Levels of carbonylated proteins and Lys-48
poly-ubiquitinated were determined by western blot. (a) Levels of poly-ubiquitinated
proteins are increased in MS white matter (WM) and gray matter (GM), and 64% of the latter
is present in protein aggregates. (b) The amount of carbonylated proteins is elevated in MS
WM and GM and essentially all of them partition into the protein aggregate fraction. Values
represent the mean ± SEM of the number of experiments shown inside the bars. *p<0.05.

5.4 Protein aggregation and its potential role in demyelinating disorders
In recent years, the study of intracellular protein aggregation has received
extraordinary impetus in most fields of biomedical sciences, particularly in
neurodegenerative diseases. The amount of protein aggregates (this study) and
carbonylated proteins (Zheng and Bizzozero, 2010) have been found to increase
with the progression of inflammatory demyelination. Carbonylation causes
protein misfolding, thereby exposing hydrophobic regions that promote
aggregation (Grune et al., 2005). Preliminary experiments from our laboratory
using post-mortem human tissues have shown that Lys-48 poly-ubiquitinated
proteins and carbonylated proteins are enriched in the detergent-insoluble
fraction of brain white and gray matter, suggesting the occurrence of protein
aggregation in MS (Figure 3). Furthermore, I also observed that an elevated
proportion of carbonylated proteins in EAE partitions into the fraction containing
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aggregated proteins (Figure 4). These data, along with those presented in
chapter 2, demonstrate for the first time the presence of aggregates in
demyelinating disorders.

Figure 4: Levels of carbonylated proteins are elevated in the spinal cord of EAE
mice, and approximately 67% of these oxidized proteins are present within
aggregates.

In general, the accumulation of protein aggregates occurs in parallel with cell
damage. However, it could be argued that formation of protein aggregates is a
consequence of a primary neurotoxic event, thus representing a marker for
neurodegeneration. Alternatively, aggregation may constitute a cellular defense
mechanism that attempts to reduce the levels of toxic free proteins (Cleveland,
1999; Tran et al., 1999). One report, however, suggests that protein aggregation
may contribute to motor neuron degeneration (Wood et al., 2003). Supporting
this idea, my own study (chapter 4) clearly shows the neurotoxic role of protein
aggregates in glutathione-depleted nPC12 cells. I believe that the discrepancy
between the various studies on whether or not protein aggregates are toxic lies
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on the type of protein aggregate. Not only aggregates can be made of different
proteins but they may also differ significantly in size (from microaggregates to
aggresomes).

Figure 5: Mechanistic model depicting how protein carbonylation may cause
protein aggregation to mediate apoptosis. Protein carbonyls are formed by
oxidation of specific amino acid residues. Moderate levels of carbonylated proteins
are maintained by an efficient removal via the proteasome. Increased rate of
oxidation and/or defective proteasomal degradation cause a large accumulation of
carbonylated proteins, followed by augmented protein aggregation and cell death.
Active autophagy removes cytoprotective aggresomes but most importantly the
cytotoxic small protein aggregates, whose build-up ultimate kills the cells.

The presence in EAE tissues of a significant number of cells containing large
protein aggregates is likely due to an increase in the amount of carbonylated
proteins along with a deficient removal. In this regard, we found that autophagy,
the major mechanism for protein aggregate clearance (Son et al., 2012), is
significantly reduced in both acute and chronic EAE, which explains the
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occurrence of juxta-nuclear protein aggregates throughout the disease. As
indicated above, while these large inclusion bodies may contribute significantly to
cell death, there is some evidence suggesting aggresomes may be
cytoprotective by sequestering the toxic, aggregated proteins (Tyedmers et al.,
2010). Also, some of the same studies propose that the smaller protein
aggregates are the cytotoxic species. Indeed, in vitro studies presented in
chapter 4 showed that during GSH depletion aggresomes do not form despite the
presence of cell death and protein aggregates determined by differential
centrifugation. Thus, it fair to speculate that the overproduction and/or failure to
clear small protein deposits is a likely contributor to neuronal damage. It will be
very important to determine the size-distribution of protein aggregates during the
course of the disease as we may find that the presence of small rather than large
aggregates correlates better with the changes in pathology and disease activity.
Multiple studies suggest that protein carbonyls promote the formation of protein
aggregates (Maisonneuve et al., 2008; Erjavec et al., 2007; Szokalska et al.,
2009; Squier, 2001; Boshard et al., 2010). Yet until now no studies have directly
established a link between protein carbonylation and protein aggregation. In this
dissertation I attempted to elucidate whether protein carbonylation precedes
protein aggregation to cause neuronal death triggered by partial glutathione
depletion. To that end, I showed (1) that scavenging protein carbonyls prevents
protein aggregation and neuronal death, and (2) that inhibiting protein
aggregation reduces cell death without affecting the levels of protein carbonyls.
This clearly demonstrates that protein oxidation is required for protein
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aggregation to mediate neural apoptosis in our model of oxidative stress. Further,
clearance of protein carbonyls by proteasomes helps in cell survival. Active
autophagy may remove both small (potentially cytotoxic) and large (potentially
cytoprotective). A mechanistic model representing my findings is shown in Figure
5.
5.5 Significance
In recent years there has been significant progress towards establishing the role
of protein aggregation in neurological disorders but little research has been
conducted to explore the possibility that protein carbonylation is the major
triggering factor in aggregate formation. The work in this dissertation provides
some answers to that possibility. My study is the first to (1) characterize cell
death in the spinal cord of EAE mice at different disease stages, (2) show
correlation between protein carbonylation, protein aggregation and cell death,
and also their correlation to clinical disability in EAE, (3) report a decrease in
autophagy in the acute and chronic phase of EAE, (4) demonstrate that protein
carbonylation causes protein aggregation to mediate neural apoptosis.
Ultimately, understanding the role of protein carbonylation and protein
aggregation in the development of CNS lesions in EAE/MS may help develop
new therapeutic approaches to treat these disorders. Furthermore, I have
obtained encouraging results using protein aggregate inhibitors to reduce cell
death in vitro and future studies will attempt to prevent cellular apoptosis in EAE
by using similar agents (see below). This strategy will serve both as a proof-of-
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principle to demonstrate the role of aggregation in demyelinating disease and as
basis for translational studies.
5.6 Future studies
Preliminary results show that protein aggregates containing poly-ubiquitinated
and carbonylated proteins are present in MS brains. I have also obtained
biochemical and histochemical evidence demonstrating the occurrence of
intracellular protein aggregates in the spinal cord of mice with MOG peptideinduced EAE. Furthermore, at least in acute EAE, the amount of protein
carbonyls, the number of protein aggregates and the extent of cell death all show
a positive correlation with the clinical symptoms. Using neuronal cultures, I
demonstrated that a moderate depletion of glutathione (GSH) (similar to that
observed in EAE) leads to increased protein oxidation, aggregation and cell
death, all of which are temporally correlated. Furthermore, inhibition of protein
aggregation with Congo Red (CR) and 2-hydroxypropyl-β-cyclodextrin (HPCD)
reduce neuronal cell death induced by partial glutathione depletion without
affecting oxidative stress or protein carbonylation, suggesting a direct link
between protein oxidation, protein aggregation and cell death. Considering these
in vitro and in vivo findings, the obvious next step is to determine whether or not
protein aggregation is pathogenic in EAE. I plan to address this issue by testing
the effectiveness of protein aggregation inhibitors at reducing neuronal and glial
cell death, tissue pathology and neurological symptoms in EAE mice.
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Protein aggregate inhibitors are agents of diverse chemical nature that have in
common the ability to aid in the refolding of proteins or to interfere with the
assembly of larger protein structures. Some of them display specificity for a
particular type of aggregates (e.g. rhodamine derivatives and anthraquinones for
tau aggregates) while others are generally nonspecific (e.g. CR, lacmoid,
cyclodextrin) (Lendel et al., 2009; Bulic et al., 2010). Based on the results shown
in chapter 4, the bioavailability of the drugs and the lack of information regarding
the type of protein aggregates present in EAE tissues, I will select two
nonspecific inhibitors: CR and the cyclodextrin derivative HPCD. I believe that
these are ideal agents to test our hypothesis since neither compound has
antioxidant properties and have been already used in vivo (Frid et al., 2007;
Burgevin et al., 1994; Gould and Scott, 2005). In fact, CR has an ameliorative
effect in cell and animal models of neurodegenerative disorders, such as
Alzheimer's, Parkinson's, Huntington's and prion diseases (Frid et al., 2006).
There are several CR analogues with increased bioavailability and blood-brain
barrier permeability that can be also tested in EAE.
I also need to identify the type of cell(s) in the EAE spinal cord where protein
aggregates accumulate, their link to cell death, and if there is any spatial
relationship between the presence of aggregates and the site of the inflammatory
lesion. Finally, I would like to develop biochemical and histochemical techniques
to characterize the size of the aggregates formed during the course of EAE. This
is an important objective since we believe that cytotoxicity is mediated by the
small-size protein aggregates. In sum, a number of novel and exciting studies
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await to be carried out to elucidate the contribution of oxidative stress and altered
proteostasis to the development of inflammatory demyelination.
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adrenal medullary
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PFA: Paraformaldehyde
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•
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